<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57491</article-id><article-id pub-id-type="doi">10.7554/eLife.57491</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Molecular basis for N-terminal alpha-synuclein acetylation by human NatB</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-187073"><name><surname>Deng</surname><given-names>Sunbin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7798-4317</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187074"><name><surname>Pan</surname><given-names>Buyan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187075"><name><surname>Gottlieb</surname><given-names>Leah</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187076"><name><surname>Petersson</surname><given-names>E James</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-148494"><name><surname>Marmorstein</surname><given-names>Ronen</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4373-4752</contrib-id><email>marmor@upenn.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Chemistry, University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Chin</surname><given-names>Jeannie</given-names></name><role>Reviewing Editor</role><aff><institution>Baylor College of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zoghbi</surname><given-names>Huda Y</given-names></name><role>Senior Editor</role><aff><institution>Texas Children's Hospital</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>04</day><month>09</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e57491</elocation-id><history><date date-type="received" iso-8601-date="2020-04-02"><day>02</day><month>04</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-09-03"><day>03</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Deng et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Deng et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57491-v2.pdf"/><abstract><p>NatB is one of three major N-terminal acetyltransferase (NAT) complexes (NatA-NatC), which co-translationally acetylate the N-termini of eukaryotic proteins. Its substrates account for about 21% of the human proteome, including well known proteins such as actin, tropomyosin, CDK2, and α-synuclein (αSyn). Human NatB (hNatB) mediated N-terminal acetylation of αSyn has been demonstrated to play key roles in the pathogenesis of Parkinson's disease and as a potential therapeutic target for hepatocellular carcinoma. Here we report the cryo-EM structure of hNatB bound to a CoA-αSyn conjugate, together with structure-guided analysis of mutational effects on catalysis. This analysis reveals functionally important differences with human NatA and <italic>Candida albicans</italic> NatB, resolves key hNatB protein determinants for αSyn N-terminal acetylation, and identifies important residues for substrate-specific recognition and acetylation by NatB enzymes. These studies have implications for developing small molecule NatB probes and for understanding the mode of substrate selection by NAT enzymes.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>NatB</kwd><kwd>α-synuclein</kwd><kwd>N-terminal acetylation</kwd><kwd>Cryo-EM</kwd><kwd>human</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35 GM118090</award-id><principal-award-recipient><name><surname>Marmorstein</surname><given-names>Ronen</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 NS103873</award-id><principal-award-recipient><name><surname>Petersson</surname><given-names>James</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P01 AG031862</award-id><principal-award-recipient><name><surname>Marmorstein</surname><given-names>Ronen</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The cryo-EM structure of the human N-terminal acetyltransferase NatB bound to a cognate N-terminal alpha-synuclein peptide reveals the molecular determinants of NatB-specific protein acetylation.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>N-terminal acetylation (NTA) is an irreversible protein modification that predominantly occurs co-translationally on eukaryotic nascent chains emerging from the ribosome exit tunnel (<xref ref-type="bibr" rid="bib4">Aksnes et al., 2019</xref>). This modification occurs on ~80% of human proteins (<xref ref-type="bibr" rid="bib3">Aksnes et al., 2016</xref>) and impacts several protein functions including complex formation (<xref ref-type="bibr" rid="bib59">Scott et al., 2011</xref>; <xref ref-type="bibr" rid="bib49">Monda et al., 2013</xref>; <xref ref-type="bibr" rid="bib78">Yang et al., 2013</xref>; <xref ref-type="bibr" rid="bib8">Arnaudo et al., 2013</xref>; <xref ref-type="bibr" rid="bib26">Gao et al., 2016</xref>), protein localization (<xref ref-type="bibr" rid="bib12">Behnia et al., 2004</xref>; <xref ref-type="bibr" rid="bib60">Setty et al., 2004</xref>; <xref ref-type="bibr" rid="bib18">Dikiy and Eliezer, 2014</xref>; <xref ref-type="bibr" rid="bib48">Miotto et al., 2015</xref>; <xref ref-type="bibr" rid="bib25">Forte et al., 2011</xref>), and the N-end rule for protein degradation (<xref ref-type="bibr" rid="bib33">Hwang et al., 2010</xref>; <xref ref-type="bibr" rid="bib61">Shemorry et al., 2013</xref>; <xref ref-type="bibr" rid="bib54">Park et al., 2015</xref>). NTA is catalyzed by a group of enzymes called N-terminal acetyltransferases (NATs), which belong to the Gcn5-related N-acetyltransferase (GNAT) family of enzymes. In humans, seven NATs have been identified to date: NatA, NatB, NatC, NatD, NatE, NatF, and NatH (<xref ref-type="bibr" rid="bib4">Aksnes et al., 2019</xref>). NatA, NatB and NatC are responsible for the majority of NTA (<xref ref-type="bibr" rid="bib67">Starheim et al., 2012</xref>). NatA and NatB are heterodimeric complexes, each with a distinctive catalytic subunit (NAA10 in NatA and NAA20 in NatB; <xref ref-type="bibr" rid="bib65">Starheim et al., 2008</xref>) and a unique auxiliary subunit (NAA15 in NatA and NAA25 in NatB; <xref ref-type="bibr" rid="bib9">Arnesen et al., 2005</xref>). NatC is a heterotrimeric complex that contains a catalytic subunit (NAA30) and two auxiliary subunits (NAA35 and NAA38; <xref ref-type="bibr" rid="bib66">Starheim et al., 2009</xref>). Structural and biochemical studies of NatA reveal that the auxiliary subunit plays an important allosteric role in substrate binding specificity and catalysis (<xref ref-type="bibr" rid="bib44">Liszczak et al., 2013</xref>) and also contributes to ribosome binding during translation (<xref ref-type="bibr" rid="bib45">Magin et al., 2017</xref>; <xref ref-type="bibr" rid="bib38">Knorr et al., 2019</xref>). NatA, NatB, and NatC exhibit distinguishable substrate specificity mainly toward the first two residues of the nascent chain N-termini. NatA accounts for 38% of the human N-terminal acetylome, acetylating small N-terminal residues after removal of the initial methionine residue (<xref ref-type="bibr" rid="bib10">Arnesen et al., 2009</xref>), while NatB modifies N-termini with sequences of MD-, ME-, MN-, and MQ- (<xref ref-type="bibr" rid="bib73">Van Damme et al., 2012</xref>; <xref ref-type="bibr" rid="bib73">Van Damme et al., 2012</xref>). NatC/E/F have overlapping substrates, acting on N-terminal methionine when it is followed by several residues excluding D, E, N, and Q (<xref ref-type="bibr" rid="bib10">Arnesen et al., 2009</xref>; <xref ref-type="bibr" rid="bib74">Van Damme et al., 2016</xref>; <xref ref-type="bibr" rid="bib69">Tercero et al., 1993</xref>; <xref ref-type="bibr" rid="bib21">Evjenth et al., 2009</xref>; <xref ref-type="bibr" rid="bib72">Van Damme et al., 2011</xref>; <xref ref-type="bibr" rid="bib68">Støve et al., 2016</xref>; <xref ref-type="bibr" rid="bib43">Liszczak et al., 2011</xref>). When another catalytic subunit (NAA50) binds to NatA, a dual enzyme complex NatE is formed (<xref ref-type="bibr" rid="bib27">Gautschi et al., 2003</xref>; <xref ref-type="bibr" rid="bib16">Deng et al., 2020</xref>), with catalytic crosstalk between NAA10 and NAA50 (<xref ref-type="bibr" rid="bib16">Deng et al., 2020</xref>; <xref ref-type="bibr" rid="bib15">Deng et al., 2019</xref>). We recently demonstrated that both NAA50, and a protein with intrinsic NatA inhibitory activity - Huntingtin-interacting protein K (HYPK; <xref ref-type="bibr" rid="bib29">Gottlieb and Marmorstein, 2018</xref>; <xref ref-type="bibr" rid="bib77">Weyer et al., 2017</xref>; <xref ref-type="bibr" rid="bib11">Arnesen et al., 2010</xref>), can bind to NatA simultaneously to form a larger tetrameric complex (<xref ref-type="bibr" rid="bib16">Deng et al., 2020</xref>). NatD and NatH are highly selective enzymes with restricted substrates, displaying activity toward H4/H2A and N-terminally processed actin, respectively (<xref ref-type="bibr" rid="bib28">Goris et al., 2018</xref>; <xref ref-type="bibr" rid="bib19">Drazic et al., 2018</xref>; <xref ref-type="bibr" rid="bib63">Song et al., 2003</xref>). The unique localization of NatF to the Golgi membrane demonstrates NTA can occur post-translationally in some cases (<xref ref-type="bibr" rid="bib2">Aksnes et al., 2015</xref>).</p><p>NatB is conserved from yeast to human in both complex composition and in its substrate specificity profile (<xref ref-type="bibr" rid="bib67">Starheim et al., 2012</xref>). In <italic>Saccharomyces cerevisiae</italic>, the deletion of NatB subunits produces more severe phenotypes compared to the knockout of NatA or NatC subunits. Deletion of either NAA20 or NAA25 leads to similar phenotypes including slower growth rate, diminished mating, defects in actin cable formation, and aberrant mitochondrial and vacuolar inheritance (<xref ref-type="bibr" rid="bib56">Polevoda et al., 2003</xref>). These observations suggest that the proper function of actin and tropomyosin requires NTA by the intact NatB complex (<xref ref-type="bibr" rid="bib56">Polevoda et al., 2003</xref>). In humans, disruption of NatB (hNatB) by knockout leads to defects in proper actin cytoskeleton structure, cell cycle progression, and cell proliferation (<xref ref-type="bibr" rid="bib65">Starheim et al., 2008</xref>; <xref ref-type="bibr" rid="bib5">Ametzazurra et al., 2008</xref>; <xref ref-type="bibr" rid="bib6">Ametzazurra et al., 2009</xref>; <xref ref-type="bibr" rid="bib50">Neri et al., 2017</xref>). In addition, hNatB is upregulated in human hepatocellular carcinoma (<xref ref-type="bibr" rid="bib5">Ametzazurra et al., 2008</xref>), where it has been suggested as a potential therapeutic target as silencing of this complex can block cell proliferation and tumor formation (<xref ref-type="bibr" rid="bib50">Neri et al., 2017</xref>). hNatB-mediated NTA of α-synuclein (αSyn) has been shown to increase αSyn stability and lipid binding, and to reduce aggregation capacity (<xref ref-type="bibr" rid="bib18">Dikiy and Eliezer, 2014</xref>; <xref ref-type="bibr" rid="bib76">Watson and Lee, 2019</xref>; <xref ref-type="bibr" rid="bib47">Mason et al., 2016</xref>; <xref ref-type="bibr" rid="bib46">Maltsev et al., 2012</xref>; <xref ref-type="bibr" rid="bib71">Trexler and Rhoades, 2012</xref>; <xref ref-type="bibr" rid="bib23">Fernández and Lucas, 2018</xref>; <xref ref-type="bibr" rid="bib22">Fauvet et al., 2012</xref>; <xref ref-type="bibr" rid="bib35">Kang et al., 2012</xref>; <xref ref-type="bibr" rid="bib34">Iyer et al., 2016</xref>). Since αSyn is a key protein in Parkinson's disease (PD; <xref ref-type="bibr" rid="bib30">Halliday et al., 2011</xref>; <xref ref-type="bibr" rid="bib64">Spillantini et al., 1998</xref>), hNatB might play an indirect role in PD pathogenesis in vivo as supported by a recent study (<xref ref-type="bibr" rid="bib75">Vinueza-Gavilanes et al., 2020</xref>). It was also recently demonstrated that NTA of αSyn increases its propensity for lipid membrane binding without altering its structural properties of the bound state (<xref ref-type="bibr" rid="bib58">Runfola et al., 2020</xref>).</p><p>Compared to the comprehensive structural and biochemical characterization of NatA (<xref ref-type="bibr" rid="bib44">Liszczak et al., 2013</xref>; <xref ref-type="bibr" rid="bib45">Magin et al., 2017</xref>; <xref ref-type="bibr" rid="bib38">Knorr et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Deng et al., 2019</xref>; <xref ref-type="bibr" rid="bib29">Gottlieb and Marmorstein, 2018</xref>; <xref ref-type="bibr" rid="bib77">Weyer et al., 2017</xref>), the study of NatB has been limited, particularly in humans. Recently, the crystal structure of <italic>Candida albicans</italic> (<italic>Ca</italic>) NatB bound to a bisubstrate CoA-peptide conjugate was determined, providing important insights into substrate specificity and NTA by caNatB (<xref ref-type="bibr" rid="bib31">Hong et al., 2017</xref>). However, hNAA20 and hNAA25 share only ~40% and~20% sequence identity with the <italic>Candida albicans</italic> homolog (<xref ref-type="bibr" rid="bib31">Hong et al., 2017</xref>), respectively. Moreover, nearly all biological studies of NatB have been conducted in <italic>Saccharomyces cerevisiae</italic> (<xref ref-type="bibr" rid="bib42">Lee et al., 2014</xref>; <xref ref-type="bibr" rid="bib13">Caesar et al., 2006</xref>; <xref ref-type="bibr" rid="bib62">Singer and Shaw, 2003</xref>), Arabidopsis (<xref ref-type="bibr" rid="bib24">Ferrández-Ayela et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Huber et al., 2020</xref>), mouse (<xref ref-type="bibr" rid="bib53">Ohyama et al., 2012</xref>), and human (<xref ref-type="bibr" rid="bib65">Starheim et al., 2008</xref>; <xref ref-type="bibr" rid="bib5">Ametzazurra et al., 2008</xref>; <xref ref-type="bibr" rid="bib6">Ametzazurra et al., 2009</xref>; <xref ref-type="bibr" rid="bib50">Neri et al., 2017</xref>) as model organisms. As a result, the mode of human NatB-mediated catalysis and αSyn-specific NatB recognition remains unresolved. In this study, we report the 3.5 Å resolution cryo-electron microscopy (cryo-EM) structure of the ~130 KDa hNatB bound to a bisubstrate CoA-αSyn conjugate together with a structure-guided analysis of mutational effects on catalytic activity. This analysis reveals functionally important structural differences between hNaB and related NAT enzymes, as well as insights into the molecular mechanisms that define αSyn and related substrates that are recognized for hNatB-mediated N-terminal acetylation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>hNatB is potently inhibited by a CoA-αSyn conjugate</title><p>While attempts to express recombinant hNatB in <italic>E. coli</italic> were unsuccessful, we found that overexpression of hNatB complex with full-length hNAA25 (residues 1–972) and C-terminally truncated hNAA20 (residue 1–163 out of 178 total residues) in baculovirus-infected Sf9 insect cells produced soluble protein that could be purified to homogeneity (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). To evaluate the activity of the recombinant hNatB, we tested it against different peptide substrates. αSyn with an N-terminal sequence of ‘MDVF’ has been widely considered as an in vivo hNatB substrate (<xref ref-type="bibr" rid="bib73">Van Damme et al., 2012</xref>; <xref ref-type="bibr" rid="bib7">Anderson et al., 2006</xref>; <xref ref-type="bibr" rid="bib52">Ohrfelt et al., 2011</xref>; <xref ref-type="bibr" rid="bib70">Theillet et al., 2016</xref>). We, therefore, incorporated this sequence into a peptide substrate named ‘MDVF’ for an in vitro acetyltransferase assay (‘MDVF’ peptide sequence: NH<sub>2</sub>-MDVFMKGRWGRPVGRRRRP-COOH). In agreement with in vivo studies (<xref ref-type="bibr" rid="bib73">Van Damme et al., 2012</xref>; <xref ref-type="bibr" rid="bib7">Anderson et al., 2006</xref>; <xref ref-type="bibr" rid="bib52">Ohrfelt et al., 2011</xref>; <xref ref-type="bibr" rid="bib70">Theillet et al., 2016</xref>), we observed that the purified recombinant hNatB was active against this ‘MDVF’ peptide, while no activity could be observed in the absence of either the enzyme or peptide (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). hNatB also showed no observable activity if either the first residue ‘M’ or the first two residues ‘MD’ in this αSyn peptide substrate was removed (‘DVFM’ peptide sequence: NH<sub>2</sub>-DVFMKGLRWGRPVGRRRRP-COOH; ‘VFMK’ peptide sequence: NH<sub>2</sub>-VFMKGLSRWGRPVGRRRRP-COOH; <xref ref-type="fig" rid="fig1">Figure 1B</xref>), suggesting that peptide substrate recognition by NatB is highly dependent on the first two N-terminal residues. To further confirm the substrate specificity of hNatB, we tested it against several previously identified peptide substrates for other NATs (‘SASE’ peptide sequence (NatA-type): NH<sub>2</sub>-SASEAGVRWGRPVGRRRRP-COOH; ‘MLRF’ peptide sequence (NatC-type): NH<sub>2</sub>-MLRFVTKRWGRPVGRRRRP-COOH; ‘SGRG’/H4 peptide sequence (NatD-type): NH<sub>2</sub>-SGRGKGGKGLGKGGAKRHR-COOH; ‘MLGP’ peptide sequence (NatE-type): NH<sub>2</sub>-MLGPEGGRWGRPVGRRRRP-COOH; <xref ref-type="fig" rid="fig1">Figure 1B</xref>). Consistent with previous results (<xref ref-type="bibr" rid="bib73">Van Damme et al., 2012</xref>), hNatB is only active toward its unique canonical substrate type, displaying no overlapping activity toward other NAT substrates.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>hNatB is active toward an α-Synuclein peptide and can be inhibited by a CoA-αSyn conjugate.</title><p>(<bold>A</bold>) Gel filtration elution profile of hNatB, using a Superdex S200 column. Coomassie-stained SDS-PAGE of peak fractions is reproduced to the right of the chromatograms. (<bold>B</bold>) Comparison of hNatB activity toward different peptide substrates. All the activities are normalized to the activity of hNatB toward αSyn peptide (MDVF). (<bold>C</bold>) The dose-response curve corresponding to the titration of CoA-αSyn conjugate (CoA-MDVFMKGLSK) into hNatB acetyltransferase reactions. The calculated IC<sub>50</sub> value is indicated. Reactions were performed in triplicate; replicates are shown in the graph as vertical dots.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57491-fig1-v2.tif"/></fig><p>In order to understand the mechanism of hNatB substrate recognition, we synthesized a bi-substrate inhibitor in which the first 10 residues of αSyn are covalently linked to CoA (<xref ref-type="bibr" rid="bib44">Liszczak et al., 2013</xref>) for enzymatic and structural studies. Half-maximum inhibitory concentration (IC<sub>50</sub>) determinations revealed that this CoA-αSyn conjugate had an IC<sub>50</sub> of about 1.63 ± 0.13 µM (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), significantly lower than the K<sub>m</sub> values we had determined for hNatB toward a ‘MDVF’ peptide (45.08 ± 3.15 µM) and acetyl-CoA (47.28 ± 5.70 µM) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Catalytic parameter of wild-type hNatB and mutants.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center">Substrate</th><th align="center">Protein</th><th align="center">K<sub>cat</sub> <break/>(min<sup>−1</sup>)</th><th align="center">K<sub>cat</sub> <break/>(normalized to WT)</th><th align="center">K<sub>m</sub> <break/>(μM)</th><th align="center">K<sub>m</sub> <break/>(normalized to WT)</th><th align="center">K<sub>cat</sub>/K<sub>m</sub> <break/>(normalized to WT)</th></tr></thead><tbody><tr><td align="center">Acetyl-CoA</td><td align="center">WT</td><td align="center">9.25 ± 0.29</td><td align="center">1</td><td align="center">47.28 ± 5.70</td><td align="center">1</td><td align="center">1</td></tr><tr><td align="center" rowspan="12">MDVF peptide</td><td align="center">WT</td><td align="center">7.63 ± 0.14</td><td align="center">1.0</td><td align="center">45.08 ± 3.15</td><td align="center">1.0</td><td align="center">1.0</td></tr><tr><td align="center">E25A</td><td align="center">8.31 ± 0.35</td><td align="center">1.1</td><td align="center">39.30 ± 6.62</td><td align="center">0.87</td><td align="center">1.3</td></tr><tr><td align="center">Y27A</td><td align="center">16.73 ± 2.11</td><td align="center">2.2</td><td align="center">75.03 ± 33.26</td><td align="center">1.7</td><td align="center">1.3</td></tr><tr><td align="center">H73A</td><td align="center">0.89 ± 0.14</td><td align="center">0.12</td><td align="center">54.76 ± 32.81</td><td align="center">1.2</td><td align="center">0.10</td></tr><tr><td align="center">R84A</td><td align="center">13.86 ± 1.75</td><td align="center">1.8</td><td align="center">320.8 ± 96.7</td><td align="center">7.1</td><td align="center">0.25</td></tr><tr><td align="center">R85A</td><td align="center">18.65 ± 1.02</td><td align="center">2.4</td><td align="center">109.6 ± 19.33</td><td align="center">2.4</td><td align="center">1.0</td></tr><tr><td align="center">G87A</td><td align="center">14.86 ± 0.56</td><td align="center">1.9</td><td align="center">78.16 ± 10.25</td><td align="center">1.7</td><td align="center">1.1</td></tr><tr><td align="center">N116A</td><td align="center">0.90 ± 0.06</td><td align="center">0.12</td><td align="center">39.86 ± 11.84</td><td align="center">0.88</td><td align="center">0.14</td></tr><tr><td align="center">Y123A</td><td align="center">0.34 ± 0.03</td><td align="center">0.045</td><td align="center">9.04 ± 3.81</td><td align="center">0.20</td><td align="center">0.23</td></tr><tr><td align="center">Y123F</td><td align="center">0.94 ± 0.06</td><td align="center">0.12</td><td align="center">42.43 ± 11.52</td><td align="center">0.94</td><td align="center">0.13</td></tr><tr><td align="center">Y137A</td><td align="center">6.43 ± 0.23</td><td align="center">0.84</td><td align="center">53.67 ± 9.63</td><td align="center">1.2</td><td align="center">0.70</td></tr><tr><td align="center">Y138A</td><td align="center">3.09 ± 0.25</td><td align="center">0.40</td><td align="center">44.23 ± 13.87</td><td align="center">0.98</td><td align="center">0.41</td></tr></tbody></table></table-wrap></sec><sec id="s2-2"><title>hNatB reveals potentially biologically significant structural differences with hNatA and caNatB</title><p>We performed single particle cryo-EM of hNatB in the presence of the CoA-αSyn conjugate. A 3.46 Å-resolution cryo-EM three-dimensional (3D) map was determined from 982,420 particles, selected from 5281 raw electron micrographs (<xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). The central core region of the EM map contains excellent sidechain density with a local resolution of ~2.5 Å, particularly around the catalytic subunit, hNAA20.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Cryo-EM data collection, refinement, and validation statistics.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"/><th valign="top">hNatB/CoA-αSyn complex <break/>EMD-21307 <break/>PDB: 6VP9 <break/>EMPIAR-10477</th></tr></thead><tbody><tr><td colspan="2" valign="top">Data collection and processing</td></tr><tr><td valign="top">Magnification</td><td align="center" valign="top">105,000</td></tr><tr><td valign="top">Voltage (keV)</td><td align="center" valign="top">300</td></tr><tr><td valign="top">Electron exposure (e/Å<sup>2</sup>)</td><td align="center" valign="top">40</td></tr><tr><td valign="top">Defocus range (μm)</td><td align="center" valign="top">−1.5 to −2.5</td></tr><tr><td valign="top">Pixel size (Å)</td><td align="center" valign="top">0.83</td></tr><tr><td valign="top">Symmetry imposed</td><td align="center" valign="top">C1</td></tr><tr><td valign="top">Initial particles (no.)</td><td align="center" valign="top">1,927,675</td></tr><tr><td valign="top">Final particles (no.)</td><td align="center" valign="top">982,420</td></tr><tr><td valign="top">Map resolution (Å)</td><td align="center" valign="top">3.46</td></tr><tr><td valign="top">FSC threshold</td><td align="center" valign="top">0.143</td></tr><tr><td valign="top">Map resolution range (Å)</td><td align="center" valign="top">2.5–4.5</td></tr><tr><td colspan="2" valign="top">Refinement</td></tr><tr><td valign="top">Initial model used (PDB code)</td><td align="center" valign="top">-</td></tr><tr><td valign="top">Model resolution (Å)</td><td align="center" valign="top">3.5</td></tr><tr><td valign="top">FSC threshold</td><td align="center" valign="top">0.5</td></tr><tr><td valign="top">Model resolution range (Å)</td><td align="center" valign="top">-</td></tr><tr><td valign="top">Map sharpening <italic>B</italic> factor (Å<sup>2</sup>)</td><td align="center" valign="top">−191.177</td></tr><tr><td colspan="2">Model composition</td></tr><tr><td>Non-hydrogen atoms</td><td align="center">8611</td></tr><tr><td>Protein residues</td><td align="center">1077</td></tr><tr><td>Ligands</td><td align="center">2</td></tr><tr><td colspan="2"><italic>B</italic> factors (Å<sup>2</sup>)</td></tr><tr><td>Protein</td><td align="center">2.51/84.68/33.39</td></tr><tr><td>Ligand</td><td align="center">17.07/19.91/19.74</td></tr><tr><td colspan="2">R.M.S. deviations</td></tr><tr><td>Bonds lengths (Å)</td><td align="center">0.011</td></tr><tr><td>Bond angles (°)</td><td align="center">1.105</td></tr><tr><td colspan="2">Validation</td></tr><tr><td>MolProbity score</td><td align="center">1.73</td></tr><tr><td>Clash score</td><td align="center">3.98</td></tr><tr><td>Poor rotamers (%)</td><td align="center">0.55</td></tr><tr><td colspan="2" valign="top">Ramachandran plot</td></tr><tr><td>Favored (%)</td><td align="center">90.10</td></tr><tr><td>Allowed (%)</td><td align="center">9.71</td></tr><tr><td>Disallowed (%)</td><td align="center">0.19</td></tr></tbody></table></table-wrap><p>Consistent with previous NAT structural studies, the atomic model of hNatB features a catalytic subunit, hNAA20, that adopts a canonical Gcn5-related N-acetyltransferase (GNAT) fold (<xref ref-type="bibr" rid="bib17">Deng and Marmorstein, 2020</xref>; <xref ref-type="bibr" rid="bib51">Neuwald and Landsman, 1997</xref>). Additionally, the model reveals that the auxiliary subunit hNAA25 is composed of a total of 39 α-helices among where the predicted first and second α-helices were built as poly-alanine due to a lack of resolvable sidechain density (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). The 39 α-helices can be roughly divided into three groups: an N-terminal region: α1-α8; a core region: α9-α29; and a C-terminal region: α30-α39 (<xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="video" rid="video1">Video 1</xref>). The N-terminal region (residue 1–164) displays relatively weak EM density compared to other regions, suggesting that it is relatively flexible (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). The eight helices of the N-terminal region form four helical bundle tetratricopeptide repeat (TPR) motifs, which often participate in protein-protein interactions. While there are no visible contacts between the N-terminal TPR motifs and hNAA20, it is possible that this region participates in ribosome association, similar to the N-terminal region of the NAA15 auxiliary subunits of <italic>Schizosaccharomyces pombe</italic> (<xref ref-type="bibr" rid="bib45">Magin et al., 2017</xref>) and <italic>Saccharomyces cerevisiae</italic> (<xref ref-type="bibr" rid="bib38">Knorr et al., 2019</xref>) NatA. The 21 helices of the core region also form a number of TPR motifs, which come together to form a ring that completely wraps around and extensively contacts hNAA20 within its hollow center (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Indeed, the interaction between hNAA20 and the TPR motifs of this core region buries a total interface area of about 2300 Å<sup>2</sup>. In the core region, it is noteworthy that there is a long α-helix (α28, ranging 30 residues) that traverses almost from one side of the complex to the other. The α28 helix closes the core ring structure, locking hNAA20 in position, and bridging the N- and C-terminal and regions. This is similar to the role played by α29-α30 of the hNAA15 auxiliary subunit of hNatA (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). The C-terminal region features helices that bundle together to protrude out of the plane of the core ring structure at an angle of ~45° (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>hNatB shows structural differences with hNatA and <italic>C.albicans</italic> NatB.</title><p>(<bold>A</bold>) hNaa20 (light orange) and hNaa25 (cyan) are shown in cartoon. The CoA-αSyn conjugate inhibitor is shown in sticks and colored as magenta. The N- and C- terminal regions are indicated as ‘N-region’ and ‘C-region’, respectively. Some helices are as labeled. (<bold>B</bold>) hNaa20 (light orange) and hNaa25 (cyan) are shown overlapped with hNatA (marine blue, PDB: 6C9M). Small molecule IP6 bound to hNatA is shown as surface representation (red). (<bold>C</bold>) hNaa20 (light orange) and hNaa25 (cyan) are shown superimposed on <italic>Ca</italic>NatB (slate blue, PDB:5K04).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57491-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Cryo-EM workflow and resolution of hNatB map.</title><p>(<bold>A</bold>) 2D and 3D classification scheme for hNatB EM map determination. (<bold>B</bold>) Local resolution map of hNatB. (<bold>C</bold>) Gold standard Fourier shell correlation (FSC) curve of hNatB EM map 3D reconstruction. (<bold>D</bold>) FSC curves of the refined model versus the overall map that it was refined against (brown); of the model refined in the first of the two independent maps used for the gold-standard FSC versus that same map (green); and of the model refined in the first of the two independent maps versus the second independent map (red).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57491-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Representative micrograph of hNatB cryo-images and hNatB model fit-in map.</title><p>(<bold>A</bold>) A representative micrograph of a hNatB frozen grids hole (<bold>B</bold>) Atomic model of hNatB fitted into the Cryo-EM map. (<bold>C</bold>) The fit of a helical segment from hNAA20 in the EM density. The contour level is 5 sigma. (<bold>D</bold>) The fit of a helical segment from hNAA25 in the EM density. The contour level is 5 sigma. (<bold>E</bold>) The fit of hNatB in the EM density at contour levels of 4 sigma, 3 sigma, and 2 sigma.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57491-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Sequence alignment of NAA25 homologs.</title><p>Species include <italic>H. sapiens</italic> (Hs), <italic>C. albicans</italic> (Ca), <italic>D. melanogaster</italic> (Dm), <italic>S. cerevisiae</italic> (Sc), and <italic>S. pombe</italic> (Sp).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57491-fig2-figsupp3-v2.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Structural comparison of hNatB and hNatA-HYPK.</title><p>(<bold>A</bold>) hNatB overlaid with hNatA-HYPK. hNatA and HYPK are colored as light salmon and red, respectively. N- and C- termini of the auxiliary subunits are indicated. (<bold>B</bold>) The extended loop connecting α31 to α32 is highlighted in green in hNatB. This loop is not present in hNatA (not shown).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57491-fig2-figsupp4-v2.tif"/></fig></fig-group><media id="video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-57491-video1.mp4"><label>Video 1.</label><caption><title>Overall view of the NatB complex.</title><p>hNaa20 (light orange) and hNaa25 (cyan) are shown in cartoon. The CoA-αSyn conjugate inhibitor is shown in sticks and colored as magenta.</p></caption></media><p>The sequence identity of the catalytic and auxiliary subunits of hNatA and hNatB are 20% and 15%, respectively. To understand how this translates to key structural differences, we superimposed the crystal structure of hNatA (PDB: 6C9M) with our model. Between the catalytic subunits, there is a high degree of superposition (1.151 Å root-mean-square deviation [RMSD] over 105 common C<sub>α</sub> atoms), except for an additional helix, α5, on the C-terminus of hNatA-NAA10, which is absent in hNatB-NAA20 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Between the auxiliary subunits, the core and N-terminal regions of both hNatA-NAA15 and hNatB-NAA25 display similar topology, although a higher degree of deviation than the catalytic subunits. The core regions both wrap around their respective catalytic subunits (8.369 Å RMSD over 262 common C<sub>α</sub> atoms), while the N-terminal regions jut off to the side (7.360 Å RMSD over 55 common C<sub>α</sub> atoms). By contrast, the C-terminal regions of hNatA-NAA15 and hNatB-NAA25 diverge significantly from one another. For hNA25, the C-terminal region of hNAA25 is oriented toward its N-terminal region, while the C-terminal region of hNAA15 is positioned ~50 Å away from the relative position of the superimposed C-terminal domain of hNAA25 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The positioning of hNAA25 may serve to promote hNAA25 intra-termini communication, which is similar to the interaction of hNatA and its regulatory protein HYPK (<xref ref-type="bibr" rid="bib29">Gottlieb and Marmorstein, 2018</xref>). HYPK, which does not interact with hNatB, interacts with both the N- and C-terminal domains of hNatA-NAA15, potentially serving as bridge to enable closer communication between these two domains (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>). Recent reports have described the role of the small molecule IP<sub>6</sub> (inositol hexakisphosphate) in hNatA activity, where it is found to act as ‘glue’ between the C-terminal and core domains in hNAA15 and hNAA10 via a series of hydrogen bonds and electrostatic interactions (<xref ref-type="bibr" rid="bib29">Gottlieb and Marmorstein, 2018</xref>; <xref ref-type="bibr" rid="bib14">Cheng et al., 2019</xref>). While no corresponding small molecules have been identified to play a similar role in hNatB, our model shows that this interaction is replaced by an extended loop that connects the α31 helix with the α32 helix of hNatB-NAA25. This loop, which is not present in hNatA-NAA15, appears to mediate hydrophobic interactions between hNatB-NAA25 and -NAA20, likely to serve a similar role as IP<sub>6</sub> (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4B</xref>).</p><p>We also compared the structures from human and the previously described <italic>C. albicans</italic> NatB (<italic>Ca</italic>NatB, PDB: 5K18). Although the two superimposed structures revealed a high degree of structural conservation (NAA20: 0.698 Å RMSD over 125 common C<sub>α</sub> atoms; NAA25 Core region: 3.267 Å RMSD over 266 common C<sub>α</sub> atoms), the N-terminal region of hNatB-NAA25 appears to overlay more closely to hNatA-NAA15 than to <italic>Ca</italic>NatB-NAA25 (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>). Compared to <italic>Ca</italic>NAA25, the N-terminal regions of hNatB-NAA25 and hNatA-NAA15 are positioned more closely to the peptide substrate binding sites of the respective catalytic subunits. Based on the role that the N-terminal yeast NatA-Naa15p regions play in ribosome docking (<xref ref-type="bibr" rid="bib45">Magin et al., 2017</xref>; <xref ref-type="bibr" rid="bib38">Knorr et al., 2019</xref>), we propose that the relative shift in the position of the N-terminal regions of the human NAT auxiliary subunits, hNAA15 and hNAA25, may reflect a difference in the mechanism for ribosome association and co-translational NTA in <italic>C. albicans</italic> compared with humans. In addition, the overlay of C-terminal regions of hNAA25 and <italic>Ca</italic>NAA25 displays an RMSD of 15.960 Å over 133 common C<sub>α</sub> atoms. We observe that the main difference that contributes to this deviation in this region is the length of helices. </p></sec><sec id="s2-3"><title>hNAA25 and hNAA20 make intimate interactions within hNatB</title><p>The hNatB/CoA-αSyn structure reveals an extensive interaction interface between the core region of the auxiliary hNAA25 and catalytic hNAA20 subunits (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The most intimate contact between the two proteins is made by the α28-α29 segment of hNAA25 and almost the entire length of hNAA20 α2, creating a large hydrophobic interface (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Residues that contribute to the interaction include Thr26, Gly28, Ile29, Pro30, Leu33, Gln34, Leu36, Ala37, His38, and Glu41 of hNAA20 and Lys535, His536, Ile537, Phe569, Asp576, Thr577, Tyr580, Ala584, Tyr 587, Lys592, Phe596, Phe599, and Leu603 of hNAA25 (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Another region of interaction, involving predominantly van der Waals interaction occurs between the hNAA20 β4-α3 loop and the hNAA25 α18-α19 loop. Here residues Lys362, Pro363, Lys362,Thr367, Cys364, and Pro363 from hNAA25 and residues Arg85, Phe83, Glu82, and Arg84 from hNAA20 contribute to this small batch of hydrophobic interface (<xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>hNAA20 and hNAA25 make intimate interactions within hNatB.</title><p>(<bold>A</bold>) hNAA20 (light orange) and hNAA25 (cyan) are shown in a cartoon with major associated interface denoted. (<bold>B–G</bold>) Zoom-in views of the hydrophobic interface regions as indicated in (<bold>A</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57491-fig3-v2.tif"/></fig><p>Additional intimate contacts between hNAA20 and hNAA25 are mediated between hNAA20 α1 helix and α26-α27 loop, and the hNAA25 α24-α25 loop, consisting of a mix of polar and non-polar interactions. A few hydrogen bonds are formed, centered around hNAA20-Asn16, between the sidechain nitrogen atoms of hNAA20-Asn16 and sidechain oxygen of hNAA25-Thr541, between the sidechain oxygen atom of hNAA20-Asn16 and sidechain nitrogen atom of hNAA25-Gln538, and between the sidechain nitrogen of hNAA20-Asn16 and the sidechain of hNAA25-Asp657 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). A salt bridge is found between the sidechain of hNAA20-Asp10 and the sidechain of hNAA25-Arg602. In addition, there are hydrophobic interactions between residues Phe15, Leu12, Phe13, Leu19, and Pro22 from hNAA20 and residues Ile537, Asp540, His536, Ala506, Phe662, Ser504, Ile542, and Leu603 from hNAA25 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>).</p><p>Different sides of hNAA20 feature several potentially hNAA25-stabilizing polar interactions. Hydrogen bonds are formed between the Asp261 sidechain of the hNAA25 α14-α15 loop and the hNAA20-Thr2 backbone nitrogen atom (<xref ref-type="fig" rid="fig3">Figure 3E</xref>), between the Glu227 backbone carbonyl group of hNAA25 α12-α13 loop and the hNAA20-Arg102 sidechain (<xref ref-type="fig" rid="fig3">Figure 3F</xref>), and between the Lys535 sidechain from NAA25 α26-α27 loop and the hNAA20-Ser141 backbone carbonyl group (<xref ref-type="fig" rid="fig3">Figure 3G</xref>).</p></sec><sec id="s2-4"><title>hNatB makes specific interactions with the first 4 N-terminal residues of αSyn</title><p>In the cryo-EM map, density for the CoA-αSyn conjugate bisubstrate inhibitor is well resolved, allowing us to confidently model the CoA portion and the first 5 N-terminal residues (of 10 residues present) of the αSyn portion (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>, <xref ref-type="video" rid="video2">Video 2</xref>). Similar to other NATs, CoA enters the catalytic active site through a groove formed by α3 and α4 of the catalytic subunit, while the peptide substrate enters the active site on the opposite side of the catalytic subunit flanked by the α1–2 and β6-β7 loops (<xref ref-type="bibr" rid="bib17">Deng and Marmorstein, 2020</xref>; <xref ref-type="fig" rid="fig4">Figure 4A</xref>). hNAA20 contains a conserved acetyl-CoA binding motif among NATs: R<sub>84</sub>R<sub>85</sub>XG<sub>87</sub>XA<sub>89</sub> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Here we observe that the positively charged hNAA20-Arg85 interacts with the negatively charged 3'-phosphorylated ADP portion of CoA to form a salt bridge while Arg84 makes Van der Waals interactions (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). A hydrogen-bonding network is formed mainly between the 5’-diphosphate group and backbone atoms of a few residues including Val79, Gly87, Ala89, and Ala90 (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>), and mediated by the sidechains of Arg85 and Gln125. The CoA molecule anchors to the binding pocket through a series of van der Waals contacts formed by residues Ser67, Val79, Leu77, Leu88, Val118, Met 122, and Tyr123 (<xref ref-type="fig" rid="fig4">Figure 4D</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>hNAA20 makes key CoA- and substrate peptide-interactions.</title><p>(<bold>A</bold>) The structure of hNAA20 bound to the CoA-αSyn conjugate bound is shown in cartoon with corresponding secondary structures labeled. (<bold>B</bold>) The fit of the CoA-αSyn conjugate ligand in the EM density map. The contour level is 4.0 sigma. (<bold>C</bold>) Interaction between CoA-αSyn conjugate and hNAA20 residues is generated with LIGPLOT (<xref ref-type="bibr" rid="bib41">Laskowski and Swindells, 2011</xref>). Hydrogen bonds are indicated by dashed green lines, and van der Waals interactions are indicated with red semicircles. (<bold>D</bold>) Highlighted polar and hydrophobic interactions between CoA-αSyn conjugate and the hNAA20 are depicted in the 3D view.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57491-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Sequence alignment of NAA20 homologs.</title><p>Species depicted include <italic>H. sapiens</italic> (Hs), <italic>C. albicans</italic> (Ca), <italic>D. melanogaster</italic> (Dm), <italic>S. cerevisiae</italic> (Sc), and <italic>S. pombe</italic> (Sp). Blue, black and magenta labeled indicate mutation sensitive residues, CoA-binding residues, and peptide-binding residues, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57491-fig4-figsupp1-v2.tif"/></fig></fig-group><media id="video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-57491-video2.mp4"><label>Video 2.</label><caption><title>Overall view of α-synuclein N-terminal interactions by NAA20.</title><p>Amino acid sidechains that mediate hydrogen bond and van der Waals interactions with α-synuclein are highlighted in a cartoon model of NAA20.</p></caption></media><p>Four N-terminal residues of αSyn participate in hNAA20 interactions. Anchoring of the αSyn peptide is mediated by protein hydrogen bonds with the backbone atoms of Met1 and Asp2 of αSyn. Hydrogen bonds are formed between the backbone N-H group of αSyn-Met1 and the backbone carbonyl group of hNAA20-Phe111, as well as the backbone carbonyl group of αSyn-Met1 with the sidechain of hNAA20-Tyr138. The backbone N-H and carbonyl of αSyn-Asp2 also form hydrogen bonds to the sidechain of Tyr27 and between the backbone carbonyl group of Asp2 and sidechain of hNAA20-Tyr27 (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Remarkably, hNAA20 contacts each of the first 4 N-terminal residue sidechains of αSyn via van der Waals interactions. The only sidechain that forms a hydrogen bond with hNAA20 is αSyn-Asp2, which hydrogen bonds with a hNAA20-His73 ring nitrogen and the hNAA20-Thr75 sidechain (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). The more extensive van der Waals interactions include the following: αSyn-Met1 interacts with hNAA20 residues Glu25, Phe27, Tyr56, and Ala76; αSyn-Asp2 interacts with hNAA20 residues Tyr27, Thr75, His73, Phe111, and Tyr138; αSyn-Val3 interacts with hNAA20 residues Tyr137 and Tyr138; and αSyn-Phe4 interacts with hNAA20 residues Glu25 and Als140. αSyn-Met5 does not appear to make specific interactions (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Consistent with the importance of the residues that mediate αSyn binding, most of the residues are highly conserved from yeast to humans (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>).</p></sec><sec id="s2-5"><title>Mutational analysis identifies key residues for hNatB catalysis and cognate substrate binding</title><p>To determine the functional importance of hNAA20 residues that appear to make important peptide or CoA substrate contacts in our model, we used an in vitro acetyltransferase assay to kinetically characterize WT and mutant hNatB proteins. Each mutant was purified to homogeneity and displayed identical gel filtration chromatography elution profiles (data not shown), indicating that they were all properly folded. We prepared alanine mutants of several residues involved in the CoA binding including Arg84, Arg85, Gly87, and Tyr123. Among them, R84A, R85A, and G87A did not show significant defects in overall protein catalytic function (<xref ref-type="table" rid="table1">Table 1</xref>). However, a Y123A mutant nearly abolished protein activity, with a 95% loss of protein activity, affecting both <italic>k<sub>cat</sub></italic> and K<sub>m</sub> (<xref ref-type="table" rid="table1">Table 1</xref>). To further interrogate the properties of this residue, we prepared a Y123F mutant which features a similar aromatic bulky sidechain but not the polar p-hydroxyl group. We observed that Y123F displayed a similar ~88% loss of <italic>k<sub>cat</sub></italic>, but had a negligible effect on the peptide K<sub>m</sub> (<xref ref-type="table" rid="table1">Table 1</xref>). These data suggested that the Tyr123 hydroxyl group is critical for catalysis but not required for substrate binding, while the aromatic ring of Tyr123 plays a role in peptide substrate binding. Given that the hydroxyl group of Tyr123 is about 3.5 Å from the sulfur atom of the CoA-αSyn conjugate and 6.3 Å away from the αSyn N-terminus, it is in a position to play a role as a general base or acid for catalysis, potentially through an intervening water molecule (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). This is analogous to the proposed general base role of Tyr73 as a general base for hNAA50 catalysis (<xref ref-type="bibr" rid="bib43">Liszczak et al., 2011</xref>; see Discussion).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Structural comparison between hNAA20 and hNAA50.</title><p>(<bold>A</bold>) Bi-substrate inhibitor-bound hNAA20 (light orange) is shown superimposed with hNAA50 (gray, PDB: 3TFY). H73, N116, and Y123 (sticks), mediate important functional roles in hNatB catalysis. (<bold>B</bold>) Residues forming the Met1 binding pocket of hNAA20 are depicted. (<bold>C</bold>) Residues forming the Met1 binding pocket of hNAA50 are depicted.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57491-fig5-v2.tif"/></fig><p>We also prepared alanine substitutions for residues that appeared to play important roles in αSyn binding: Glu25, Tyr27, His73, Tyr137, and Tyr138. We were surprised to find that mutations of hNatB residues that mediated backbone hydrogen bond interactions, Y27A and Y138A, had relatively modest effects on αSyn peptide NTA with Y27A showing ~twofold higher K<sub>m</sub> and Y138A showing ~twofold reduced K<sub>cat</sub>, together suggesting that sidechain contacts might dominate the binding energy (<xref ref-type="table" rid="table1">Table 1</xref>). Consistent with this, and our structural observations, we found that H73A produced a ~90% reduction in activity (<xref ref-type="table" rid="table1">Table 1</xref>). This correlates with the importance of the His73 hydrogen bond and van der Waals contacts with αSyn-Asp2. Of note, other cognate hNatB sidechain residues at position 2, Glu, Gln, and Asn would also be well positioned to form hydrogen bonds with His73. Together, hNAA20-His73 appears to play a critical role in cognate substrate recognition by hNatB. hNatB-Asn116 is a highly conserved NatB residue (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>) that caps the hNAA20 α4 helix, which also harbors the putative catalytic residue, Tyr123, and is also in position to make a water-mediated hydrogen bond with to CoA pantetheine nitrogen (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). This observation suggests that Asn116 could play an important functional role. To test this, we prepared and evaluated an N116A mutant and, consistent with our hypothesis, Ans116, we found that this mutant leads to ~90% loss in activity (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Taken together, our structural and mutational analysis of hNatB highlight the functional importance of hNatB-NAA20 residues His73, Asn116, and Tyr123 in hNatB-mediated N-terminal acetylation. While Tyr123 appears to play a critical catalytic role, potentially as a general base and/or acid for catalysis; His73 appears to play an important role in the recognition of substrate residue two and Asn116 likely plays a structural role (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Each of these residues could employ a bridging water molecule to mediate their functional roles, although these putative water molecules are not visible at the current resolution of our structure.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Since the identification of hNatB more than a decade ago, many studies have shown that it N-terminally acetylates important proteins such as actin, tropomyosin, CDK2, and α-Syn, and its function has connections to diseases such as hepatocellular carcinoma and Parkinson's disease (<xref ref-type="bibr" rid="bib65">Starheim et al., 2008</xref>; <xref ref-type="bibr" rid="bib56">Polevoda et al., 2003</xref>; <xref ref-type="bibr" rid="bib5">Ametzazurra et al., 2008</xref>; <xref ref-type="bibr" rid="bib50">Neri et al., 2017</xref>; <xref ref-type="bibr" rid="bib30">Halliday et al., 2011</xref>; <xref ref-type="bibr" rid="bib64">Spillantini et al., 1998</xref>). Despite its clear biological importance, hNatB-mediated NTA by hNatB remained poorly understood. Here we developed a CoA-αSyn conjugate hNatB inhibitor, determined the cryo-EM structure of CoA-αSyn inhibitor-bound hNatB, and carried out associated structure-guided mutagenesis and activity assays. This has led to the identification of functionally important differences with human NatA and <italic>C. albicans</italic> NatB. These studies have also provided evidence for important hNatB-specific elements responsible for αSyn recognition and N-terminal acetylation, providing direct implications for NatB recognition of other canonical substrate proteins.</p><p>Consistent with previous studies, we have demonstrated that hNatB acetylates a cognate ‘MD’ N-terminus and is unable to N-terminally acetylate non-cognate N-termini that are substrates for other NATs such as NatA, NatC, and NatE. We demonstrated for the first time that hNatB can acetylate an α-Syn peptide in vitro, directly linking hNatB to NTA of α-Syn. We have also demonstrated that αSyn peptides lacking the Met1 or both the Met1 and Asp2, do not serve as hNatB substrates, confirming the strict substrate specificity of hNatB. This is consistent with our structural model showing significant interactions between hNatB-NAA20 and both the first and second N-terminal residues of an αSyn peptide, with important but less extensive interactions with the third and fourth residues. This hierarchy of interactions likely explains how NatB enzymes can accommodate cognate substrates that diverge at positions three and four.</p><p>Here we have presented hNatB-αSyn interactions that can be used to rationalize the substrate specificity of hNatB: N-terminal sequences containing ‘MD-', ‘ME-', ‘MN-', and ‘MQ-'. αSyn-Met1 sits in a hydrophobic pocket that comfortably accommodates a methionine residue, whereas shorter sidechains or longer polar or charged sidechains would fit poorly (<xref ref-type="fig" rid="fig5">Figure 5B–C</xref>). The nature of this binding pocket is similar to the described hNAA50 recognition of Met1 (<xref ref-type="bibr" rid="bib43">Liszczak et al., 2011</xref>; <xref ref-type="fig" rid="fig5">Figure 5B–C</xref>). Although both of hNAA50 and hNAA20 can N-terminally acetylate peptides with Met at the first position, no overlapping activity has been observed. This can be rationalized based on the chemical properties of the second residue in the cognate peptide. We find that the αSyn-Asp2 sidechain forms hydrogen bonds with the hNAA20 sidechains His73 and Thr75. These polar residues in the peptide binding site of hNAA20 would likely serve as poor acceptors of the largely hydrophobic residues targeted by hNAA50. The hNatB substrate client profile featuring D-, E-, N-, or Q-residues in position two is consistent with the mechanisms of substrate recognition observed in the binding pocket for αSyn-Asp2. The aliphatic regions of each of these sidechains (D, E, N, Q) would all benefit from the extensive hNatB van der Waals interactions surrounding the aliphatic region for αSyn-Asp2 (Tyr27, His73, Thr75, Phe111, and Tyr138). This second residue would also form a hydrogen bond interaction with His73 and Thr75, which may accommodate the carboxyl sidechains of both the shorter D- and N- and longer E- and Q- sidechains. Notably, His73 and Thr75 are strictly conserved from yeast to man (<xref ref-type="fig" rid="fig5">Figure 5</xref> and <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). In contrast, shorter polar or nonpolar sidechains would less efficiently fill the pocket for residue two, while larger polar or charged sidechains would likely result in steric clashes. In agreement with this, we have demonstrated that H73A mutation has a severe impact on hNatB catalysis (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>The hNatB/CoA-αSyn structure has implications for the mode of hNatB catalysis. While previous studies have suggested that hNAA50-Tyr31 plays an important role in catalysis, mutation of the corresponding hNaa20 residue, Tyr27, had minimal effects on hNatB kinetic parameters. Strikingly, our mutational analysis has identified the functional importance of hNatB-NAA20 residues His73, Asn116, and Tyr123, although Tyr123 is the only residue that is in position to play a catalytic role (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Specifically, Tyr123 is in position to play a catalytic role, potentially as a general base and/or acid, through a bridging water molecule (although a water molecule is not visible at the current resolution). Interestingly, hNAA50 contains a tyrosine residue at the same position (hNAA50-Tyr124), although the mechanistic significance of this tyrosine residue has not yet been described (<xref ref-type="bibr" rid="bib43">Liszczak et al., 2011</xref>). It would be of interest to determine if hNAA50-Tyr124 also plays an important catalytic role, similar to the corresponding hNAA20-Tyr123 of hNatB.</p><p>The biological importance of hNatB and its connection to various disease processes highlights it as an important target for probe and inhibitor development. Indeed, a recent study highlights hNatB as a therapeutic target for αSyn toxicity (<xref ref-type="bibr" rid="bib75">Vinueza-Gavilanes et al., 2020</xref>). Our development of a CoA-αSyn conjugate bisubstrate with an IC<sub>50</sub> of ~1.6 µM represents a step in this direction, although the structural information provided here could further aid to the rational development of more drug-like hNatB inhibitors with possible therapeutic applications.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or <break/>resource</th><th valign="top">Designation</th><th valign="top">Source or <break/>reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pFASTBac HTA-hNAA20(1-163) (plasmid)</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Protein expression plasmid for <italic>hNAA20 (in Sf9 cells)</italic> and found in the Materials and methods section of this paper</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pFASTBac HTA-6HIS-TEV-hNAA25(1-972) (plasmid)</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Protein expression plasmid for <italic>hNAA25 (in Sf9 cells)</italic> and found in the Materials and methods section of this paper</td></tr><tr><td valign="top">Cell line (<italic>Spodoptera frugiperda</italic>)</td><td valign="top">Sf9 cells</td><td valign="top">ThermoFisher</td><td valign="top">cat #12659017</td><td valign="top">For protein expression</td></tr><tr><td valign="top">Peptide, recombinant protein</td><td valign="top">MVDF peptide</td><td valign="top">GenScript</td><td valign="top">NH<sub>2</sub>-MDVFMKGRWGRPVGRRRRP-COOH</td><td valign="top"/></tr><tr><td valign="top">Peptide, recombinant protein</td><td valign="top">‘SASE’ peptide</td><td valign="top">GenScript</td><td valign="top">NH<sub>2</sub>-SASEAGVRWGRPVGRRRRP-COOH</td><td valign="top"/></tr><tr><td valign="top">Peptide, recombinant <break/>protein</td><td valign="top">‘MLGP’ peptide</td><td valign="top">GenScript</td><td valign="top">NH<sub>2</sub>-MLGPEGGRWGRPVGRRRRP-COOH</td><td valign="top"/></tr><tr><td valign="top">Peptide, recombinant protein</td><td valign="top">‘SGRG’/H4 peptide</td><td valign="top">GenScript</td><td valign="top">NH<sub>2</sub>-SGRGKGGKGLGKGGAKRHR-COOH</td><td valign="top"/></tr><tr><td valign="top">Peptide, recombinant protein</td><td valign="top">‘MLRF’ peptide</td><td valign="top">GenScript</td><td valign="top">NH<sub>2</sub>-ML RFVTKRWGRPVGRRRRP-COOH</td><td valign="top"/></tr><tr><td valign="top">Peptide, recombinant protein</td><td valign="top">‘DVFM’ peptide</td><td valign="top">GenScript</td><td valign="top">NH<sub>2</sub>-DVFMKGLRWGRPVGRRRRP-COOH</td><td valign="top"/></tr><tr><td valign="top">Peptide, recombinant protein</td><td valign="top">‘VFMK’ peptide</td><td valign="top">GenScript</td><td valign="top">NH<sub>2</sub>-VFMKGLSRWGRPVGRRRRP-COOH</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">[<sup>14</sup>C] Acetyl-CoA (4 mCi/mmol)</td><td valign="top">PerkinElmer Life Sciences</td><td valign="top">Cat#NEC313050UC</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">P81 Phosphocellulose squares</td><td valign="top">EMD Millipore</td><td valign="top">Cat#20–134</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">RELION</td><td valign="top"><xref ref-type="bibr" rid="bib82">Zivanov et al., 2018</xref></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">MotionCor2</td><td valign="top"><xref ref-type="bibr" rid="bib80">Zheng et al., 2017</xref></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">COOT</td><td valign="top"><xref ref-type="bibr" rid="bib20">Emsley and Cowtan, 2004</xref></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">PHENIX</td><td valign="top"><xref ref-type="bibr" rid="bib1">Adams et al., 2010</xref></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">ResMap</td><td valign="top"><xref ref-type="bibr" rid="bib40">Kucukelbir et al., 2014</xref></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Gctf</td><td valign="top"><xref ref-type="bibr" rid="bib79">Zhang, 2016</xref></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Prism 5.0</td><td valign="top">GraphPad</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">PyMOL</td><td valign="top">Schrodinger LLC</td><td valign="top"/><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Protein expression and purification</title><p>hNAA20 with a C-terminal truncation (1–163 out of 178 residues) and full-length hNAA25 were cloned into two separate insect cell expression vectors pFASTBac HTA. hNAA20 was untagged, while hNAA25 contained a Tobacco-etch virus (TEV)-cleavable N-terminal 6xHis-tag. Human NatB complex (hNAA20<sup>1-163</sup>/hNAA25<sup>FL</sup>) was obtained by co-expressing these two plasmids in Sf9 (<italic>S. frugiperda</italic>) cells (ThermoFisher, cat# 12659017), and purified as described previously (<xref ref-type="bibr" rid="bib29">Gottlieb and Marmorstein, 2018</xref>). Sf9 cells were grown to a density of 1 × 10<sup>6</sup> cells/mL and infected using the amplified hNAA20<sup>1-163</sup>/hNAA25<sup>FL</sup> baculovirus to an MOI (multiplicity of infection) of 1–2. The cells were grown at 27°C and harvested for 48 hr post-infection by centrifugation. Cell pellets were resuspended in lysis buffer (25 mM Tris, pH 8.0, 300 mM NaCl, 10 mM Imidazole, 10 mM β-ME, 0.1 mg/mL PMSF, DNase, and complete, EDTA-free protease inhibitor tablet) and lysed by sonication. After centrifugation, the supernatant was isolated and passed over Ni-NTA resin (Thermo Scientific), which was subsequently washed with 10 column volumes of lysis buffer. Protein was eluted with a buffer with 25 mM Tris, pH 8.0, 300 mM imidazole, 200 mM NaCl, 10 mM β-ME, which was dialyzed into a buffer with 25 mM HEPES pH 7.5 50 mM NaCl 10 mM β-ME. Ion-exchange was carried out with an SP ion-exchange column (GE Healthcare) in dialysis buffer with a salt gradient (50–750 mM NaCl). Peak fractions were concentrated to ~0.5 mL with a 50 kDa concentrator (Amicon Ultra, Millipore), and loaded onto an S200 gel-filtration column (GE Healthcare) in a buffer with 25 mM HEPES, pH 7.5, 200 mM NaCl, and 1 mM TCEP. Proteins were aliquoted, snap-frozen in liquid nitrogen, and stored at −80°C for further use. Protein harboring mutations were generated with the QuickChange protocol (Stratagene) and obtained following the same expression and purification protocol as described for the wild-type protein. Primers synthesized for the generation mutant constructs are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-2"><title>Acetyltransferase activity assays</title><p>All acetyltransferase assays were carried out at room temperature in a reaction buffer containing 75 mM HEPES, pH 7.5, 120 mM NaCl, 1 mM DTT as described (<xref ref-type="bibr" rid="bib16">Deng et al., 2020</xref>; <xref ref-type="bibr" rid="bib15">Deng et al., 2019</xref>). The ‘MDVF’ peptide substrate was based on the first seven amino acid of α-Synuclein (‘MDVF’ peptide: NH<sub>2</sub>-MDVFMKGRWGRPVGRRRRP-COOH; ‘SASE’ peptide: NH<sub>2</sub>-SASEAGVRWGRPVGRRRRP-COOH; ‘MLGP’ peptide: NH<sub>2</sub>-MLGPEGGRWGRPVGRRRRP-COOH; ‘SGRG’/H4 peptide: NH<sub>2</sub>-SGRGKGGKG LGKGGAKRHR-COOH; ‘MLRF’ peptide: NH<sub>2</sub>-ML RFVTKRWGRPVGRRRRP-COOH; ‘DVFM’ peptide: NH<sub>2</sub>-DVFMKGLRWGRPVGRRRRP-COOH; ‘VFMK’ peptide: NH<sub>2</sub>-VFMKGLSRWGRPVGRRRRP-COOH; GenScript). Reactions were performed in triplicate. To determine steady-state catalytic parameters of hNatB with respect to acetyl-CoA, 100 nM hNatB was mixed with a saturating concentration of ‘MDVF’ peptide substrate (500 μM) and varying concentrations (1.95 μM to 1 mM) of acetyl-CoA (<sup>14</sup>C-labeled, 4 mCi mmol<sup>−1</sup>; PerkinElmer Life Sciences) for 10 min reactions. To determine steady-state catalytic parameters of hNatB with respect to peptide substrate, 100 nM hNatB was mixed with saturating concentrations of acetyl- CoA (300 μM, <sup>14</sup>C-labeled) and varying concentrations of ‘MVDF’ peptide (1.95 μM to 1 mM) for 10 min. Reactions were quenched by adding the solution to P81 paper discs (Whatman). Unreacted acetyl-CoA was removed by washing the paper discs in buffer with 10 mM HEPES, pH 7.5, at least three times, each 5 min. The paper discs were then dried with acetone and transferred to 4 mL scintillation fluid for signal measurement (Packard Tri-Carb 1500 liquid scintillation analyzer). Data was fitted to a Michaelis–Menten equation in GraphPad Prism to calculate kinetic parameters. Kinetic parameters on mutants with respect to peptide were carried out in the same condition as for wild type, with 300 μM <sup>14</sup>C labeled acetyl-CoA and varied peptide concentration (1.95 μM to 1 mM). All radioactive count values were converted to molar units with a standard curve created with known concentrations of radioactive acetyl-CoA added to scintillation fluid. GraphPad Prism (version 5.01), was used for all data fitting to the Michaelis–Menten equation. For IC<sub>50</sub> determination of the CoA-αSyn conjugate, 100 nM hNatB was mixed with 500 μM ‘MVDF’ peptide and 300 μM <sup>14</sup>C labeled acetyl-CoA, and inhibitor concentrations were varied (0.23 μM to 13.44 μM). Data were fit to a sigmoidal dose-response curve with GraphPad Prism (version 5.01). Errors represent s.d. (n = 3).</p></sec><sec id="s4-3"><title>Cryo-EM data collection</title><p>For initial sample screening, 0.6 mg/mL fresh hNatB sample with three-molar excess bisubstrate was used. hNatB particles on these grids exhibited a severe preferred orientation, which generated an incorrect 3D initial model (data not shown). To solve this issue, 1 μL of 0.05% NP-40 was mixed with 20 μL of hNatB (4 mg/mL). 3 μL of this sample was applied to glow-discharged Quantinfoil R1.2/1.3 holey carbon support grids, blotted and plunged into liquid ethane, using an FEI Vitrobot Mark IV. An FEI TF20 was used for screening the grids and data collection was performed with a Titan Krios equipped with a K3 Summit direct detector (Gatan), at a magnification of 105,000×, with defocus values from −0.1 to −2.0 µm. Each stack was exposed in super-resolution mode with a total dose of 45 e<sup>-</sup>/Å<sup>2</sup>, resulting in 35 frames per stack. Image stacks were automatically collected with Latitude software (Gatan, Inc).</p></sec><sec id="s4-4"><title>Cryo-EM data processing</title><p>Original image stacks were summed and corrected for drift and beam-induced motion at the micrograph level using MotionCor2 (<xref ref-type="bibr" rid="bib80">Zheng et al., 2017</xref>), and binned twofold, resulting in a pixel size of 0.83 Å/pixel. Defocus estimation and the resolution range of each micrograph were performed with Gctf (<xref ref-type="bibr" rid="bib79">Zhang, 2016</xref>). About 3000 particles were manually picked to generate several rough 2D class averages. Representative 2D classes were used to automatically pick ~1,927,673 particles from 5281 micrographs in Relion 3.0 (<xref ref-type="bibr" rid="bib37">Kimanius et al., 2016</xref>; <xref ref-type="bibr" rid="bib82">Zivanov et al., 2018</xref>). All particles were extracted and binned to accelerate the 2D and 3D classification. After bad particles were removed by 2D and 3D classification, 982, 420 particles were used for auto-refinement and per-particle CTF refinement. After refinement, a mask was created in Relion with an initial binarization threshold of 0.005, covering the protein complex and extending the binary map and soft-edge by 12 pixels. The map was sharpened with the created mask by estimating B-factor automatically in Relion. The final map was refined to an overall resolution of 3.46 Å, with local resolution estimated by Resmap (<xref ref-type="bibr" rid="bib40">Kucukelbir et al., 2014</xref>). We attempted particle polishing on this data set but this surprisingly resulted in artifactual density in the resulting map. We believe that this was due to some small defects in the K3 camera during data collection, which corrupted the particle polishing process. We, therefore, did not perform particle polishing on this data set. Raw micrographs were deposited in EMPIAR with access ID of EMPIAR-10477.</p></sec><sec id="s4-5"><title>Cryo-EM model building and refinement</title><p>The hNatB atomic model was manually built de novo using the program COOT (<xref ref-type="bibr" rid="bib20">Emsley and Cowtan, 2004</xref>) according to the cryo-EM map, with the guidance of predicted secondary structure and bulky residues such as Phe, Tyr, Trp, and Arg. The first two alpha helices of hNAA25 were built as poly-alanine due to the lack of tracible density in the 3D map. The complete model was then refined by real-space refinement in PHENIX (<xref ref-type="bibr" rid="bib1">Adams et al., 2010</xref>). All representations of cryo-EM density and structural models were performed with Chimera (<xref ref-type="bibr" rid="bib55">Pettersen et al., 2004</xref>) and PyMol (<ext-link ext-link-type="uri" xlink:href="https://pymol.org/2/">https://pymol.org/2/</ext-link>). The sequence alignments with secondary structure display were created by ESPript 3.0 (<xref ref-type="bibr" rid="bib57">Robert and Gouet, 2014</xref>). hNAA25 TPR predictions were performed using the TPRpred server (<xref ref-type="bibr" rid="bib36">Karpenahalli et al., 2007</xref>; <xref ref-type="bibr" rid="bib81">Zimmermann et al., 2018</xref>; <ext-link ext-link-type="uri" xlink:href="https://toolkit.tuebingen.mpg.de/">https://toolkit.tuebingen.mpg.de/</ext-link>#/tools/tprpred). The surface area calculation was performed using PDBePISA (<xref ref-type="bibr" rid="bib39">Krissinel and Henrick, 2007</xref>; Proteins, Interfaces, Structures, and Assemblies; <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/pdbe/pisa/">http://www.ebi.ac.uk/pdbe/pisa/</ext-link>).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This work was supported by NIH grant R35 GM118090 awarded to RM and R01 NS103873 awarded to EJP. BP thanks the University of Pennsylvania for support through a Dissertation Completion Fellowship. We acknowledge the support of the Perelman School of Medicine, University of Pennsylvania DNA Sequencing Core Facility and D Schultz and E Dean from the University of Pennsylvania High Throughput Screening Core Facility for providing the Sf9 cells expressing hNatB for this study. We thank Dr. Zuo Biao and Dr. Sudheer Molugu from the University of Pennsylvania Electron Microscopy Resource Lab for help with initial cryo-grid screening; and Dr. Darrah Johnson-McDaniel from the Beckman Center for Cryo-EM at the University of Pennsylvania for technical assistance on data collection. We also thank Dr. Xuepeng Wei for help in data analysis and discussion.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Data curation, Supervision, Funding acquisition, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Sequence of primers for preparing mutants.</title><p>Both the forward and reverse primers for each mutant is indicated.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-57491-supp1-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-57491-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Cryo-EM data submissions to the Protein Data Bank (PDB code 6VP9), Electron Microscopy Data Bank (EMD code 21307) and Electron Microscopy Public Image Archive (EMPIAR-10477).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>S</given-names></name><name><surname>Marmorstein</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Cryo-EM structure of human NatB complex</data-title><source>RCSB Protein Data Bank</source><pub-id assigning-authority="PDB" pub-id-type="accession" xlink:href="http://www.rcsb.org/structure/6VP9">6VP9</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>S</given-names></name><name><surname>Marmorstein</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>cryo-EM data for NatB complex</data-title><source>Electron Microscopy Data Bank</source><pub-id assigning-authority="EMDB" pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/pdbe/entry/emdb/EMD-21307">EMD-21307</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>S</given-names></name><name><surname>Marmorstein</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>cryo-EM data for NatB comple</data-title><source>Electron Microscopy Public Image Archive</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/pdbe/emdb/empiar/entry/10477/">10477</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>PD</given-names></name><name><surname>Afonine</surname> <given-names>PV</given-names></name><name><surname>Bunkóczi</surname> <given-names>G</given-names></name><name><surname>Chen</surname> <given-names>VB</given-names></name><name><surname>Davis</surname> <given-names>IW</given-names></name><name><surname>Echols</surname> <given-names>N</given-names></name><name><surname>Headd</surname> <given-names>JJ</given-names></name><name><surname>Hung</surname> <given-names>LW</given-names></name><name><surname>Kapral</surname> <given-names>GJ</given-names></name><name><surname>Grosse-Kunstleve</surname> <given-names>RW</given-names></name><name><surname>McCoy</surname> <given-names>AJ</given-names></name><name><surname>Moriarty</surname> <given-names>NW</given-names></name><name><surname>Oeffner</surname> <given-names>R</given-names></name><name><surname>Read</surname> <given-names>RJ</given-names></name><name><surname>Richardson</surname> <given-names>DC</given-names></name><name><surname>Richardson</surname> <given-names>JS</given-names></name><name><surname>Terwilliger</surname> <given-names>TC</given-names></name><name><surname>Zwart</surname> <given-names>PH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title><italic>PHENIX</italic>: a comprehensive Python-based system for macromolecular structure solution</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>66</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id><pub-id pub-id-type="pmid">20124702</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aksnes</surname> <given-names>H</given-names></name><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Goris</surname> <given-names>M</given-names></name><name><surname>Starheim</surname> <given-names>KK</given-names></name><name><surname>Marie</surname> <given-names>M</given-names></name><name><surname>Støve</surname> <given-names>SI</given-names></name><name><surname>Hoel</surname> <given-names>C</given-names></name><name><surname>Kalvik</surname> <given-names>TV</given-names></name><name><surname>Hole</surname> <given-names>K</given-names></name><name><surname>Glomnes</surname> <given-names>N</given-names></name><name><surname>Furnes</surname> <given-names>C</given-names></name><name><surname>Ljostveit</surname> <given-names>S</given-names></name><name><surname>Ziegler</surname> <given-names>M</given-names></name><name><surname>Niere</surname> <given-names>M</given-names></name><name><surname>Gevaert</surname> <given-names>K</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>An organellar nα-acetyltransferase, naa60, acetylates cytosolic N termini of transmembrane proteins and maintains golgi integrity</article-title><source>Cell Reports</source><volume>10</volume><fpage>1362</fpage><lpage>1374</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.01.053</pub-id><pub-id pub-id-type="pmid">25732826</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aksnes</surname> <given-names>H</given-names></name><name><surname>Drazic</surname> <given-names>A</given-names></name><name><surname>Marie</surname> <given-names>M</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>First things first: vital protein marks by N-Terminal acetyltransferases</article-title><source>Trends in Biochemical Sciences</source><volume>41</volume><fpage>746</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2016.07.005</pub-id><pub-id pub-id-type="pmid">27498224</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aksnes</surname> <given-names>H</given-names></name><name><surname>Ree</surname> <given-names>R</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Co-translational, Post-translational, and Non-catalytic roles of N-Terminal acetyltransferases</article-title><source>Molecular Cell</source><volume>73</volume><fpage>1097</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.02.007</pub-id><pub-id pub-id-type="pmid">30878283</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ametzazurra</surname> <given-names>A</given-names></name><name><surname>Larrea</surname> <given-names>E</given-names></name><name><surname>Civeira</surname> <given-names>MP</given-names></name><name><surname>Prieto</surname> <given-names>J</given-names></name><name><surname>Aldabe</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Implication of human N-α-acetyltransferase 5 in cellular proliferation and carcinogenesis</article-title><source>Oncogene</source><volume>27</volume><fpage>7296</fpage><lpage>7306</lpage><pub-id pub-id-type="doi">10.1038/onc.2008.332</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ametzazurra</surname> <given-names>A</given-names></name><name><surname>Gázquez</surname> <given-names>C</given-names></name><name><surname>Lasa</surname> <given-names>M</given-names></name><name><surname>Larrea</surname> <given-names>E</given-names></name><name><surname>Prieto</surname> <given-names>J</given-names></name><name><surname>Aldabe</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Characterization of the human Nalpha-terminal acetyltransferase B enzymatic complex</article-title><source>BMC Proceedings</source><volume>3</volume><elocation-id>S4</elocation-id><pub-id pub-id-type="doi">10.1186/1753-6561-3-s6-s4</pub-id><pub-id pub-id-type="pmid">19660097</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>JP</given-names></name><name><surname>Walker</surname> <given-names>DE</given-names></name><name><surname>Goldstein</surname> <given-names>JM</given-names></name><name><surname>de Laat</surname> <given-names>R</given-names></name><name><surname>Banducci</surname> <given-names>K</given-names></name><name><surname>Caccavello</surname> <given-names>RJ</given-names></name><name><surname>Barbour</surname> <given-names>R</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Kling</surname> <given-names>K</given-names></name><name><surname>Lee</surname> <given-names>M</given-names></name><name><surname>Diep</surname> <given-names>L</given-names></name><name><surname>Keim</surname> <given-names>PS</given-names></name><name><surname>Shen</surname> <given-names>X</given-names></name><name><surname>Chataway</surname> <given-names>T</given-names></name><name><surname>Schlossmacher</surname> <given-names>MG</given-names></name><name><surname>Seubert</surname> <given-names>P</given-names></name><name><surname>Schenk</surname> <given-names>D</given-names></name><name><surname>Sinha</surname> <given-names>S</given-names></name><name><surname>Gai</surname> <given-names>WP</given-names></name><name><surname>Chilcote</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic lewy body disease</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>29739</fpage><lpage>29752</lpage><pub-id pub-id-type="doi">10.1074/jbc.M600933200</pub-id><pub-id pub-id-type="pmid">16847063</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnaudo</surname> <given-names>N</given-names></name><name><surname>Fernández</surname> <given-names>IS</given-names></name><name><surname>McLaughlin</surname> <given-names>SH</given-names></name><name><surname>Peak-Chew</surname> <given-names>SY</given-names></name><name><surname>Rhodes</surname> <given-names>D</given-names></name><name><surname>Martino</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The N-terminal acetylation of Sir3 stabilizes its binding to the nucleosome core particle</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>20</volume><fpage>1119</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2641</pub-id><pub-id pub-id-type="pmid">23934150</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnesen</surname> <given-names>T</given-names></name><name><surname>Anderson</surname> <given-names>D</given-names></name><name><surname>Baldersheim</surname> <given-names>C</given-names></name><name><surname>Lanotte</surname> <given-names>M</given-names></name><name><surname>Varhaug</surname> <given-names>JE</given-names></name><name><surname>Lillehaug</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Identification and characterization of the human ARD1-NATH protein acetyltransferase complex</article-title><source>Biochemical Journal</source><volume>386</volume><fpage>433</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1042/BJ20041071</pub-id><pub-id pub-id-type="pmid">15496142</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnesen</surname> <given-names>T</given-names></name><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Polevoda</surname> <given-names>B</given-names></name><name><surname>Helsens</surname> <given-names>K</given-names></name><name><surname>Evjenth</surname> <given-names>R</given-names></name><name><surname>Colaert</surname> <given-names>N</given-names></name><name><surname>Varhaug</surname> <given-names>JE</given-names></name><name><surname>Vandekerckhove</surname> <given-names>J</given-names></name><name><surname>Lillehaug</surname> <given-names>JR</given-names></name><name><surname>Sherman</surname> <given-names>F</given-names></name><name><surname>Gevaert</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans</article-title><source>PNAS</source><volume>106</volume><fpage>8157</fpage><lpage>8162</lpage><pub-id pub-id-type="doi">10.1073/pnas.0901931106</pub-id><pub-id pub-id-type="pmid">19420222</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnesen</surname> <given-names>T</given-names></name><name><surname>Starheim</surname> <given-names>KK</given-names></name><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Evjenth</surname> <given-names>R</given-names></name><name><surname>Dinh</surname> <given-names>H</given-names></name><name><surname>Betts</surname> <given-names>MJ</given-names></name><name><surname>Ryningen</surname> <given-names>A</given-names></name><name><surname>Vandekerckhove</surname> <given-names>J</given-names></name><name><surname>Gevaert</surname> <given-names>K</given-names></name><name><surname>Anderson</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The chaperone-like protein HYPK acts together with NatA in Cotranslational N-terminal acetylation and prevention of huntingtin aggregation</article-title><source>Molecular and Cellular Biology</source><volume>30</volume><fpage>1898</fpage><lpage>1909</lpage><pub-id pub-id-type="doi">10.1128/MCB.01199-09</pub-id><pub-id pub-id-type="pmid">20154145</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behnia</surname> <given-names>R</given-names></name><name><surname>Panic</surname> <given-names>B</given-names></name><name><surname>Whyte</surname> <given-names>JR</given-names></name><name><surname>Munro</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title><italic>Targeting of the Arf-like GTPase Arl3p to the golgi requires N-terminal acetylation and the membrane protein</italic> Sys1p</article-title><source>Nature Cell Biology</source><volume>6</volume><fpage>405</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1038/ncb1120</pub-id><pub-id pub-id-type="pmid">15077113</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caesar</surname> <given-names>R</given-names></name><name><surname>Warringer</surname> <given-names>J</given-names></name><name><surname>Blomberg</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Physiological importance and identification of novel targets for the N-terminal acetyltransferase NatB</article-title><source>Eukaryotic Cell</source><volume>5</volume><fpage>368</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1128/EC.5.2.368-378.2006</pub-id><pub-id pub-id-type="pmid">16467477</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>H</given-names></name><name><surname>Gottlieb</surname> <given-names>L</given-names></name><name><surname>Marchi</surname> <given-names>E</given-names></name><name><surname>Kleyner</surname> <given-names>R</given-names></name><name><surname>Bhardwaj</surname> <given-names>P</given-names></name><name><surname>Rope</surname> <given-names>AF</given-names></name><name><surname>Rosenheck</surname> <given-names>S</given-names></name><name><surname>Moutton</surname> <given-names>S</given-names></name><name><surname>Philippe</surname> <given-names>C</given-names></name><name><surname>Eyaid</surname> <given-names>W</given-names></name><name><surname>Alkuraya</surname> <given-names>FS</given-names></name><name><surname>Toribio</surname> <given-names>J</given-names></name><name><surname>Mena</surname> <given-names>R</given-names></name><name><surname>Prada</surname> <given-names>CE</given-names></name><name><surname>Stessman</surname> <given-names>H</given-names></name><name><surname>Bernier</surname> <given-names>R</given-names></name><name><surname>Wermuth</surname> <given-names>M</given-names></name><name><surname>Kauffmann</surname> <given-names>B</given-names></name><name><surname>Blaumeiser</surname> <given-names>B</given-names></name><name><surname>Kooy</surname> <given-names>RF</given-names></name><name><surname>Baralle</surname> <given-names>D</given-names></name><name><surname>Mancini</surname> <given-names>GMS</given-names></name><name><surname>Conway</surname> <given-names>SJ</given-names></name><name><surname>Xia</surname> <given-names>F</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Meng</surname> <given-names>L</given-names></name><name><surname>Mihajlovic</surname> <given-names>L</given-names></name><name><surname>Marmorstein</surname> <given-names>R</given-names></name><name><surname>Lyon</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15</article-title><source>Human Molecular Genetics</source><volume>28</volume><fpage>2900</fpage><lpage>2919</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddz111</pub-id><pub-id pub-id-type="pmid">31127942</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname> <given-names>S</given-names></name><name><surname>Magin</surname> <given-names>RS</given-names></name><name><surname>Wei</surname> <given-names>X</given-names></name><name><surname>Pan</surname> <given-names>B</given-names></name><name><surname>Petersson</surname> <given-names>EJ</given-names></name><name><surname>Marmorstein</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Structure and mechanism of acetylation by the N-Terminal dual enzyme NatA/Naa50 complex</article-title><source>Structure</source><volume>27</volume><fpage>1057</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1016/j.str.2019.04.014</pub-id><pub-id pub-id-type="pmid">31155310</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname> <given-names>S</given-names></name><name><surname>McTiernan</surname> <given-names>N</given-names></name><name><surname>Wei</surname> <given-names>X</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name><name><surname>Marmorstein</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Molecular basis for N-terminal acetylation by human NatE and its modulation by HYPK</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>818</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-14584-7</pub-id><pub-id pub-id-type="pmid">32042062</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname> <given-names>S</given-names></name><name><surname>Marmorstein</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Protein N-Terminal acetylation: structural basis, mechanism, versatility, and regulation</article-title><source>Trends in Biochemical Sciences</source><volume>8</volume><elocation-id>005</elocation-id><pub-id pub-id-type="doi">10.1016/j.tibs.2020.08.005</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dikiy</surname> <given-names>I</given-names></name><name><surname>Eliezer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>N-terminal acetylation stabilizes N-terminal helicity in lipid- and micelle-bound α-synuclein and increases its affinity for physiological membranes</article-title><source>Journal of Biological Chemistry</source><volume>289</volume><fpage>3652</fpage><lpage>3665</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.512459</pub-id><pub-id pub-id-type="pmid">24338013</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drazic</surname> <given-names>A</given-names></name><name><surname>Aksnes</surname> <given-names>H</given-names></name><name><surname>Marie</surname> <given-names>M</given-names></name><name><surname>Boczkowska</surname> <given-names>M</given-names></name><name><surname>Varland</surname> <given-names>S</given-names></name><name><surname>Timmerman</surname> <given-names>E</given-names></name><name><surname>Foyn</surname> <given-names>H</given-names></name><name><surname>Glomnes</surname> <given-names>N</given-names></name><name><surname>Rebowski</surname> <given-names>G</given-names></name><name><surname>Impens</surname> <given-names>F</given-names></name><name><surname>Gevaert</surname> <given-names>K</given-names></name><name><surname>Dominguez</surname> <given-names>R</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>NAA80 is actin's N-terminal acetyltransferase and regulates cytoskeleton assembly and cell motility</article-title><source>PNAS</source><volume>115</volume><fpage>4399</fpage><lpage>4404</lpage><pub-id pub-id-type="doi">10.1073/pnas.1718336115</pub-id><pub-id pub-id-type="pmid">29581253</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname> <given-names>P</given-names></name><name><surname>Cowtan</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title><italic>Coot</italic>: model-building tools for molecular graphics</article-title><source>Acta Crystallographica. Section D, Biological Crystallography</source><volume>60</volume><fpage>2126</fpage><lpage>2132</lpage><pub-id pub-id-type="doi">10.1107/S0907444904019158</pub-id><pub-id pub-id-type="pmid">15572765</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evjenth</surname> <given-names>R</given-names></name><name><surname>Hole</surname> <given-names>K</given-names></name><name><surname>Karlsen</surname> <given-names>OA</given-names></name><name><surname>Ziegler</surname> <given-names>M</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name><name><surname>Lillehaug</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Human Naa50p (Nat5/San) displays both protein N alpha- and N epsilon-acetyltransferase activity</article-title><source>The Journal of Biological Chemistry</source><volume>284</volume><fpage>31122</fpage><lpage>31129</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.001347</pub-id><pub-id pub-id-type="pmid">19744929</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fauvet</surname> <given-names>B</given-names></name><name><surname>Fares</surname> <given-names>MB</given-names></name><name><surname>Samuel</surname> <given-names>F</given-names></name><name><surname>Dikiy</surname> <given-names>I</given-names></name><name><surname>Tandon</surname> <given-names>A</given-names></name><name><surname>Eliezer</surname> <given-names>D</given-names></name><name><surname>Lashuel</surname> <given-names>HA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Characterization of semisynthetic and naturally Nα-acetylated α-synuclein in vitro and in intact cells: implications for aggregation and cellular properties of α-synuclein</article-title><source>The Journal of Biological Chemistry</source><volume>287</volume><fpage>28243</fpage><lpage>28262</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.383711</pub-id><pub-id pub-id-type="pmid">22718772</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernández</surname> <given-names>RD</given-names></name><name><surname>Lucas</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mass spectrometry data confirming tetrameric α-synuclein N-terminal acetylation</article-title><source>Data in Brief</source><volume>20</volume><fpage>1686</fpage><lpage>1691</lpage><pub-id pub-id-type="doi">10.1016/j.dib.2018.09.026</pub-id><pub-id pub-id-type="pmid">30263921</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrández-Ayela</surname> <given-names>A</given-names></name><name><surname>Micol-Ponce</surname> <given-names>R</given-names></name><name><surname>Sánchez-García</surname> <given-names>AB</given-names></name><name><surname>Alonso-Peral</surname> <given-names>MM</given-names></name><name><surname>Micol</surname> <given-names>JL</given-names></name><name><surname>Ponce</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mutation of an Arabidopsis NatB N-alpha-terminal acetylation complex component causes pleiotropic developmental defects</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e80697</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0080697</pub-id><pub-id pub-id-type="pmid">24244708</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forte</surname> <given-names>GM</given-names></name><name><surname>Pool</surname> <given-names>MR</given-names></name><name><surname>Stirling</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>N-terminal acetylation inhibits protein targeting to the endoplasmic reticulum</article-title><source>PLOS Biology</source><volume>9</volume><elocation-id>e1001073</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001073</pub-id><pub-id pub-id-type="pmid">21655302</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>J</given-names></name><name><surname>Barroso</surname> <given-names>C</given-names></name><name><surname>Zhang</surname> <given-names>P</given-names></name><name><surname>Kim</surname> <given-names>HM</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Labrador</surname> <given-names>L</given-names></name><name><surname>Lightfoot</surname> <given-names>J</given-names></name><name><surname>Gerashchenko</surname> <given-names>MV</given-names></name><name><surname>Labunskyy</surname> <given-names>VM</given-names></name><name><surname>Dong</surname> <given-names>MQ</given-names></name><name><surname>Martinez-Perez</surname> <given-names>E</given-names></name><name><surname>Colaiácovo</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>N-terminal acetylation promotes synaptonemal complex assembly in <italic>C. elegans</italic></article-title><source>Genes &amp; Development</source><volume>30</volume><fpage>2404</fpage><lpage>2416</lpage><pub-id pub-id-type="doi">10.1101/gad.277350.116</pub-id><pub-id pub-id-type="pmid">27881602</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautschi</surname> <given-names>M</given-names></name><name><surname>Just</surname> <given-names>S</given-names></name><name><surname>Mun</surname> <given-names>A</given-names></name><name><surname>Ross</surname> <given-names>S</given-names></name><name><surname>Rücknagel</surname> <given-names>P</given-names></name><name><surname>Dubaquié</surname> <given-names>Y</given-names></name><name><surname>Ehrenhofer-Murray</surname> <given-names>A</given-names></name><name><surname>Rospert</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The yeast N(alpha)-acetyltransferase NatA is quantitatively anchored to the ribosome and interacts with nascent polypeptides</article-title><source>Molecular and Cellular Biology</source><volume>23</volume><fpage>7403</fpage><lpage>7414</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.20.7403-7414.2003</pub-id><pub-id pub-id-type="pmid">14517307</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goris</surname> <given-names>M</given-names></name><name><surname>Magin</surname> <given-names>RS</given-names></name><name><surname>Foyn</surname> <given-names>H</given-names></name><name><surname>Myklebust</surname> <given-names>LM</given-names></name><name><surname>Varland</surname> <given-names>S</given-names></name><name><surname>Ree</surname> <given-names>R</given-names></name><name><surname>Drazic</surname> <given-names>A</given-names></name><name><surname>Bhambra</surname> <given-names>P</given-names></name><name><surname>Støve</surname> <given-names>SI</given-names></name><name><surname>Baumann</surname> <given-names>M</given-names></name><name><surname>Haug</surname> <given-names>BE</given-names></name><name><surname>Marmorstein</surname> <given-names>R</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structural determinants and cellular environment define processed actin as the sole substrate of the N-terminal acetyltransferase NAA80</article-title><source>PNAS</source><volume>115</volume><fpage>4405</fpage><lpage>4410</lpage><pub-id pub-id-type="doi">10.1073/pnas.1719251115</pub-id><pub-id pub-id-type="pmid">29581307</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottlieb</surname> <given-names>L</given-names></name><name><surname>Marmorstein</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structure of human NatA and its regulation by the huntingtin interacting protein HYPK</article-title><source>Structure</source><volume>26</volume><fpage>925</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1016/j.str.2018.04.003</pub-id><pub-id pub-id-type="pmid">29754825</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halliday</surname> <given-names>GM</given-names></name><name><surname>Holton</surname> <given-names>JL</given-names></name><name><surname>Revesz</surname> <given-names>T</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neuropathology underlying clinical variability in patients with synucleinopathies</article-title><source>Acta Neuropathologica</source><volume>122</volume><fpage>187</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1007/s00401-011-0852-9</pub-id><pub-id pub-id-type="pmid">21720849</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname> <given-names>H</given-names></name><name><surname>Cai</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Ding</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Han</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Molecular basis of substrate specific acetylation by N-Terminal acetyltransferase NatB</article-title><source>Structure</source><volume>25</volume><fpage>641</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1016/j.str.2017.03.003</pub-id><pub-id pub-id-type="pmid">28380339</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname> <given-names>M</given-names></name><name><surname>Bienvenut</surname> <given-names>WV</given-names></name><name><surname>Linster</surname> <given-names>E</given-names></name><name><surname>Stephan</surname> <given-names>I</given-names></name><name><surname>Armbruster</surname> <given-names>L</given-names></name><name><surname>Sticht</surname> <given-names>C</given-names></name><name><surname>Layer</surname> <given-names>D</given-names></name><name><surname>Lapouge</surname> <given-names>K</given-names></name><name><surname>Meinnel</surname> <given-names>T</given-names></name><name><surname>Sinning</surname> <given-names>I</given-names></name><name><surname>Giglione</surname> <given-names>C</given-names></name><name><surname>Hell</surname> <given-names>R</given-names></name><name><surname>Wirtz</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>NatB-Mediated N-Terminal acetylation affects growth and biotic stress responses</article-title><source>Plant Physiology</source><volume>182</volume><fpage>792</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1104/pp.19.00792</pub-id><pub-id pub-id-type="pmid">31744933</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>CS</given-names></name><name><surname>Shemorry</surname> <given-names>A</given-names></name><name><surname>Varshavsky</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>N-terminal acetylation of cellular proteins creates specific degradation signals</article-title><source>Science</source><volume>327</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1126/science.1183147</pub-id><pub-id pub-id-type="pmid">20110468</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname> <given-names>A</given-names></name><name><surname>Roeters</surname> <given-names>SJ</given-names></name><name><surname>Schilderink</surname> <given-names>N</given-names></name><name><surname>Hommersom</surname> <given-names>B</given-names></name><name><surname>Heeren</surname> <given-names>RM</given-names></name><name><surname>Woutersen</surname> <given-names>S</given-names></name><name><surname>Claessens</surname> <given-names>MM</given-names></name><name><surname>Subramaniam</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The impact of N-terminal acetylation of α-Synuclein on phospholipid membrane binding and fibril structure</article-title><source>Journal of Biological Chemistry</source><volume>291</volume><fpage>21110</fpage><lpage>21122</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.726612</pub-id><pub-id pub-id-type="pmid">27531743</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>L</given-names></name><name><surname>Moriarty</surname> <given-names>GM</given-names></name><name><surname>Woods</surname> <given-names>LA</given-names></name><name><surname>Ashcroft</surname> <given-names>AE</given-names></name><name><surname>Radford</surname> <given-names>SE</given-names></name><name><surname>Baum</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>N-terminal acetylation of α-synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer</article-title><source>Protein Science</source><volume>21</volume><fpage>911</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1002/pro.2088</pub-id><pub-id pub-id-type="pmid">22573613</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karpenahalli</surname> <given-names>MR</given-names></name><name><surname>Lupas</surname> <given-names>AN</given-names></name><name><surname>Söding</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>TPRpred: a tool for prediction of TPR-, PPR- and SEL1-like repeats from protein sequences</article-title><source>BMC Bioinformatics</source><volume>8</volume><elocation-id>2</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-8-2</pub-id><pub-id pub-id-type="pmid">17199898</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimanius</surname> <given-names>D</given-names></name><name><surname>Forsberg</surname> <given-names>BO</given-names></name><name><surname>Scheres</surname> <given-names>SH</given-names></name><name><surname>Lindahl</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2</article-title><source>eLife</source><volume>5</volume><elocation-id>e18722</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.18722</pub-id><pub-id pub-id-type="pmid">27845625</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knorr</surname> <given-names>AG</given-names></name><name><surname>Schmidt</surname> <given-names>C</given-names></name><name><surname>Tesina</surname> <given-names>P</given-names></name><name><surname>Berninghausen</surname> <given-names>O</given-names></name><name><surname>Becker</surname> <given-names>T</given-names></name><name><surname>Beatrix</surname> <given-names>B</given-names></name><name><surname>Beckmann</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ribosome-NatA architecture reveals that rRNA expansion segments coordinate N-terminal acetylation</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>26</volume><fpage>35</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1038/s41594-018-0165-y</pub-id><pub-id pub-id-type="pmid">30559462</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krissinel</surname> <given-names>E</given-names></name><name><surname>Henrick</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Inference of macromolecular assemblies from crystalline state</article-title><source>Journal of Molecular Biology</source><volume>372</volume><fpage>774</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2007.05.022</pub-id><pub-id pub-id-type="pmid">17681537</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucukelbir</surname> <given-names>A</given-names></name><name><surname>Sigworth</surname> <given-names>FJ</given-names></name><name><surname>Tagare</surname> <given-names>HD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Quantifying the local resolution of cryo-EM density maps</article-title><source>Nature Methods</source><volume>11</volume><fpage>63</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2727</pub-id><pub-id pub-id-type="pmid">24213166</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laskowski</surname> <given-names>RA</given-names></name><name><surname>Swindells</surname> <given-names>MB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>LigPlot+: multiple ligand-protein interaction diagrams for drug discovery</article-title><source>Journal of Chemical Information and Modeling</source><volume>51</volume><fpage>2778</fpage><lpage>2786</lpage><pub-id pub-id-type="doi">10.1021/ci200227u</pub-id><pub-id pub-id-type="pmid">21919503</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>KE</given-names></name><name><surname>Ahn</surname> <given-names>JY</given-names></name><name><surname>Kim</surname> <given-names>JM</given-names></name><name><surname>Hwang</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Synthetic lethal screen of NAA20, a catalytic subunit gene of NatB N-terminal acetylase in <italic>Saccharomyces cerevisiae</italic></article-title><source>Journal of Microbiology</source><volume>52</volume><fpage>842</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1007/s12275-014-3694-z</pub-id><pub-id pub-id-type="pmid">25163837</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liszczak</surname> <given-names>G</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name><name><surname>Marmorstein</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structure of a ternary Naa50p (NAT5/SAN) N-terminal acetyltransferase complex reveals the molecular basis for substrate-specific acetylation</article-title><source>Journal of Biological Chemistry</source><volume>286</volume><fpage>37002</fpage><lpage>37010</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.282863</pub-id><pub-id pub-id-type="pmid">21900231</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liszczak</surname> <given-names>G</given-names></name><name><surname>Goldberg</surname> <given-names>JM</given-names></name><name><surname>Foyn</surname> <given-names>H</given-names></name><name><surname>Petersson</surname> <given-names>EJ</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name><name><surname>Marmorstein</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Molecular basis for N-terminal acetylation by the heterodimeric NatA complex</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>20</volume><fpage>1098</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2636</pub-id><pub-id pub-id-type="pmid">23912279</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magin</surname> <given-names>RS</given-names></name><name><surname>Deng</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Cooperman</surname> <given-names>B</given-names></name><name><surname>Marmorstein</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Probing the interaction between NatA and the ribosome for co-translational protein acetylation</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0186278</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0186278</pub-id><pub-id pub-id-type="pmid">29016658</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maltsev</surname> <given-names>AS</given-names></name><name><surname>Ying</surname> <given-names>J</given-names></name><name><surname>Bax</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Impact of N-terminal acetylation of α-synuclein on its random coil and lipid binding properties</article-title><source>Biochemistry</source><volume>51</volume><fpage>5004</fpage><lpage>5013</lpage><pub-id pub-id-type="doi">10.1021/bi300642h</pub-id><pub-id pub-id-type="pmid">22694188</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname> <given-names>RJ</given-names></name><name><surname>Paskins</surname> <given-names>AR</given-names></name><name><surname>Dalton</surname> <given-names>CF</given-names></name><name><surname>Smith</surname> <given-names>DP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Copper binding and subsequent aggregation of α-Synuclein are modulated by N-Terminal acetylation and ablated by the H50Q missense mutation</article-title><source>Biochemistry</source><volume>55</volume><fpage>4737</fpage><lpage>4741</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.6b00708</pub-id><pub-id pub-id-type="pmid">27517125</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miotto</surname> <given-names>MC</given-names></name><name><surname>Valiente-Gabioud</surname> <given-names>AA</given-names></name><name><surname>Rossetti</surname> <given-names>G</given-names></name><name><surname>Zweckstetter</surname> <given-names>M</given-names></name><name><surname>Carloni</surname> <given-names>P</given-names></name><name><surname>Selenko</surname> <given-names>P</given-names></name><name><surname>Griesinger</surname> <given-names>C</given-names></name><name><surname>Binolfi</surname> <given-names>A</given-names></name><name><surname>Fernández</surname> <given-names>CO</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Copper binding to the N-terminally acetylated, naturally occurring form of alpha-synuclein induces local helical folding</article-title><source>Journal of the American Chemical Society</source><volume>137</volume><fpage>6444</fpage><lpage>6447</lpage><pub-id pub-id-type="doi">10.1021/jacs.5b01911</pub-id><pub-id pub-id-type="pmid">25939020</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monda</surname> <given-names>JK</given-names></name><name><surname>Scott</surname> <given-names>DC</given-names></name><name><surname>Miller</surname> <given-names>DJ</given-names></name><name><surname>Lydeard</surname> <given-names>J</given-names></name><name><surname>King</surname> <given-names>D</given-names></name><name><surname>Harper</surname> <given-names>JW</given-names></name><name><surname>Bennett</surname> <given-names>EJ</given-names></name><name><surname>Schulman</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structural conservation of distinctive N-terminal acetylation-dependent interactions across a family of mammalian NEDD8 ligation enzymes</article-title><source>Structure</source><volume>21</volume><fpage>42</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.str.2012.10.013</pub-id><pub-id pub-id-type="pmid">23201271</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neri</surname> <given-names>L</given-names></name><name><surname>Lasa</surname> <given-names>M</given-names></name><name><surname>Elosegui-Artola</surname> <given-names>A</given-names></name><name><surname>D'Avola</surname> <given-names>D</given-names></name><name><surname>Carte</surname> <given-names>B</given-names></name><name><surname>Gazquez</surname> <given-names>C</given-names></name><name><surname>Alve</surname> <given-names>S</given-names></name><name><surname>Roca-Cusachs</surname> <given-names>P</given-names></name><name><surname>Iñarrairaegui</surname> <given-names>M</given-names></name><name><surname>Herrero</surname> <given-names>J</given-names></name><name><surname>Prieto</surname> <given-names>J</given-names></name><name><surname>Sangro</surname> <given-names>B</given-names></name><name><surname>Aldabe</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma</article-title><source>Oncotarget</source><volume>8</volume><fpage>40967</fpage><lpage>40981</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.17332</pub-id><pub-id pub-id-type="pmid">28498797</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuwald</surname> <given-names>AF</given-names></name><name><surname>Landsman</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>GCN5-related histone N-acetyltransferases belong to a diverse superfamily that includes the yeast SPT10 protein</article-title><source>Trends in Biochemical Sciences</source><volume>22</volume><fpage>154</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/S0968-0004(97)01034-7</pub-id><pub-id pub-id-type="pmid">9175471</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohrfelt</surname> <given-names>A</given-names></name><name><surname>Zetterberg</surname> <given-names>H</given-names></name><name><surname>Andersson</surname> <given-names>K</given-names></name><name><surname>Persson</surname> <given-names>R</given-names></name><name><surname>Secic</surname> <given-names>D</given-names></name><name><surname>Brinkmalm</surname> <given-names>G</given-names></name><name><surname>Wallin</surname> <given-names>A</given-names></name><name><surname>Mulugeta</surname> <given-names>E</given-names></name><name><surname>Francis</surname> <given-names>PT</given-names></name><name><surname>Vanmechelen</surname> <given-names>E</given-names></name><name><surname>Aarsland</surname> <given-names>D</given-names></name><name><surname>Ballard</surname> <given-names>C</given-names></name><name><surname>Blennow</surname> <given-names>K</given-names></name><name><surname>Westman-Brinkmalm</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method</article-title><source>Neurochemical Research</source><volume>36</volume><fpage>2029</fpage><lpage>2042</lpage><pub-id pub-id-type="doi">10.1007/s11064-011-0527-x</pub-id><pub-id pub-id-type="pmid">21674238</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohyama</surname> <given-names>K</given-names></name><name><surname>Yasuda</surname> <given-names>K</given-names></name><name><surname>Onga</surname> <given-names>K</given-names></name><name><surname>Kakizuka</surname> <given-names>A</given-names></name><name><surname>Mori</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Spatio-temporal expression pattern of the NatB complex, Nat5/Mdm20 in the developing mouse brain: implications for co-operative versus non-co-operative actions of Mdm20 and Nat5</article-title><source>Gene Expression Patterns</source><volume>12</volume><fpage>36</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.gep.2011.11.001</pub-id><pub-id pub-id-type="pmid">22101279</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>SE</given-names></name><name><surname>Kim</surname> <given-names>JM</given-names></name><name><surname>Seok</surname> <given-names>OH</given-names></name><name><surname>Cho</surname> <given-names>H</given-names></name><name><surname>Wadas</surname> <given-names>B</given-names></name><name><surname>Kim</surname> <given-names>SY</given-names></name><name><surname>Varshavsky</surname> <given-names>A</given-names></name><name><surname>Hwang</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Control of mammalian G protein signaling by N-terminal acetylation and the N-end rule pathway</article-title><source>Science</source><volume>347</volume><fpage>1249</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.1126/science.aaa3844</pub-id><pub-id pub-id-type="pmid">25766235</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname> <given-names>EF</given-names></name><name><surname>Goddard</surname> <given-names>TD</given-names></name><name><surname>Huang</surname> <given-names>CC</given-names></name><name><surname>Couch</surname> <given-names>GS</given-names></name><name><surname>Greenblatt</surname> <given-names>DM</given-names></name><name><surname>Meng</surname> <given-names>EC</given-names></name><name><surname>Ferrin</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>UCSF chimera--a visualization system for exploratory research and analysis</article-title><source>Journal of Computational Chemistry</source><volume>25</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id><pub-id pub-id-type="pmid">15264254</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polevoda</surname> <given-names>B</given-names></name><name><surname>Cardillo</surname> <given-names>TS</given-names></name><name><surname>Doyle</surname> <given-names>TC</given-names></name><name><surname>Bedi</surname> <given-names>GS</given-names></name><name><surname>Sherman</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Nat3p and Mdm20p are required for function of yeast NatB Nalpha-terminal acetyltransferase and of actin and tropomyosin</article-title><source>Journal of Biological Chemistry</source><volume>278</volume><fpage>30686</fpage><lpage>30697</lpage><pub-id pub-id-type="doi">10.1074/jbc.M304690200</pub-id><pub-id pub-id-type="pmid">12783868</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname> <given-names>X</given-names></name><name><surname>Gouet</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Deciphering key features in protein structures with the new ENDscript server</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>W320</fpage><lpage>W324</lpage><pub-id pub-id-type="doi">10.1093/nar/gku316</pub-id><pub-id pub-id-type="pmid">24753421</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Runfola</surname> <given-names>M</given-names></name><name><surname>De Simone</surname> <given-names>A</given-names></name><name><surname>Vendruscolo</surname> <given-names>M</given-names></name><name><surname>Dobson</surname> <given-names>CM</given-names></name><name><surname>Fusco</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The N-terminal acetylation of α-Synuclein changes the affinity for lipid membranes but not the structural properties of the bound state</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>204</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-57023-4</pub-id><pub-id pub-id-type="pmid">31937832</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname> <given-names>DC</given-names></name><name><surname>Monda</surname> <given-names>JK</given-names></name><name><surname>Bennett</surname> <given-names>EJ</given-names></name><name><surname>Harper</surname> <given-names>JW</given-names></name><name><surname>Schulman</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>N-terminal acetylation acts as an avidity enhancer within an interconnected multiprotein complex</article-title><source>Science</source><volume>334</volume><fpage>674</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1126/science.1209307</pub-id><pub-id pub-id-type="pmid">21940857</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setty</surname> <given-names>SR</given-names></name><name><surname>Strochlic</surname> <given-names>TI</given-names></name><name><surname>Tong</surname> <given-names>AH</given-names></name><name><surname>Boone</surname> <given-names>C</given-names></name><name><surname>Burd</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Golgi targeting of ARF-like GTPase Arl3p requires its Nalpha-acetylation and the integral membrane protein Sys1p</article-title><source>Nature Cell Biology</source><volume>6</volume><fpage>414</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1038/ncb1121</pub-id><pub-id pub-id-type="pmid">15077114</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shemorry</surname> <given-names>A</given-names></name><name><surname>Hwang</surname> <given-names>CS</given-names></name><name><surname>Varshavsky</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Control of protein quality and stoichiometries by N-terminal acetylation and the N-end rule pathway</article-title><source>Molecular Cell</source><volume>50</volume><fpage>540</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.03.018</pub-id><pub-id pub-id-type="pmid">23603116</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname> <given-names>JM</given-names></name><name><surname>Shaw</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mdm20 protein functions with Nat3 protein to acetylate Tpm1 protein and regulate tropomyosin-actin interactions in budding yeast</article-title><source>PNAS</source><volume>100</volume><fpage>7644</fpage><lpage>7649</lpage><pub-id pub-id-type="doi">10.1073/pnas.1232343100</pub-id><pub-id pub-id-type="pmid">12808144</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>OK</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Waterborg</surname> <given-names>JH</given-names></name><name><surname>Sternglanz</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A<italic>n N</italic> <sup>α</sup> -Acetyltransferase Responsible for Acetylatio<italic>n</italic> of the <italic>N</italic>-terminal Residues of Histones H4 and H2A</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>38109</fpage><lpage>38112</lpage><pub-id pub-id-type="doi">10.1074/jbc.C300355200</pub-id><pub-id pub-id-type="pmid">12915400</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spillantini</surname> <given-names>MG</given-names></name><name><surname>Crowther</surname> <given-names>RA</given-names></name><name><surname>Jakes</surname> <given-names>R</given-names></name><name><surname>Hasegawa</surname> <given-names>M</given-names></name><name><surname>Goedert</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>alpha-Synuclein in filamentous inclusions of lewy bodies from Parkinson's disease and dementia with lewy bodies</article-title><source>PNAS</source><volume>95</volume><fpage>6469</fpage><lpage>6473</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.11.6469</pub-id><pub-id pub-id-type="pmid">9600990</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starheim</surname> <given-names>KK</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name><name><surname>Gromyko</surname> <given-names>D</given-names></name><name><surname>Ryningen</surname> <given-names>A</given-names></name><name><surname>Varhaug</surname> <given-names>JE</given-names></name><name><surname>Lillehaug</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Identification of the human N(alpha)-acetyltransferase complex B (hNatB): a complex important for cell-cycle progression</article-title><source>Biochemical Journal</source><volume>415</volume><fpage>325</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1042/BJ20080658</pub-id><pub-id pub-id-type="pmid">18570629</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starheim</surname> <given-names>KK</given-names></name><name><surname>Gromyko</surname> <given-names>D</given-names></name><name><surname>Evjenth</surname> <given-names>R</given-names></name><name><surname>Ryningen</surname> <given-names>A</given-names></name><name><surname>Varhaug</surname> <given-names>JE</given-names></name><name><surname>Lillehaug</surname> <given-names>JR</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Knockdown of human N alpha-terminal acetyltransferase complex C leads to p53-dependent apoptosis and aberrant human Arl8b localization</article-title><source>Molecular and Cellular Biology</source><volume>29</volume><fpage>3569</fpage><lpage>3581</lpage><pub-id pub-id-type="doi">10.1128/MCB.01909-08</pub-id><pub-id pub-id-type="pmid">19398576</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starheim</surname> <given-names>KK</given-names></name><name><surname>Gevaert</surname> <given-names>K</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Protein N-terminal acetyltransferases: when the start matters</article-title><source>Trends in Biochemical Sciences</source><volume>37</volume><fpage>152</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2012.02.003</pub-id><pub-id pub-id-type="pmid">22405572</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Støve</surname> <given-names>SI</given-names></name><name><surname>Magin</surname> <given-names>RS</given-names></name><name><surname>Foyn</surname> <given-names>H</given-names></name><name><surname>Haug</surname> <given-names>BE</given-names></name><name><surname>Marmorstein</surname> <given-names>R</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Crystal structure of the Golgi-Associated human Nα-Acetyltransferase 60 reveals the molecular determinants for Substrate-Specific acetylation</article-title><source>Structure</source><volume>24</volume><fpage>1044</fpage><lpage>1056</lpage><pub-id pub-id-type="doi">10.1016/j.str.2016.04.020</pub-id><pub-id pub-id-type="pmid">27320834</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tercero</surname> <given-names>JC</given-names></name><name><surname>Dinman</surname> <given-names>JD</given-names></name><name><surname>Wickner</surname> <given-names>RB</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Yeast MAK3 N-acetyltransferase recognizes the N-terminal four amino acids of the major coat protein (gag) of the L-A double-stranded RNA virus</article-title><source>Journal of Bacteriology</source><volume>175</volume><fpage>3192</fpage><lpage>3194</lpage><pub-id pub-id-type="doi">10.1128/JB.175.10.3192-3194.1993</pub-id><pub-id pub-id-type="pmid">8491733</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theillet</surname> <given-names>FX</given-names></name><name><surname>Binolfi</surname> <given-names>A</given-names></name><name><surname>Bekei</surname> <given-names>B</given-names></name><name><surname>Martorana</surname> <given-names>A</given-names></name><name><surname>Rose</surname> <given-names>HM</given-names></name><name><surname>Stuiver</surname> <given-names>M</given-names></name><name><surname>Verzini</surname> <given-names>S</given-names></name><name><surname>Lorenz</surname> <given-names>D</given-names></name><name><surname>van Rossum</surname> <given-names>M</given-names></name><name><surname>Goldfarb</surname> <given-names>D</given-names></name><name><surname>Selenko</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structural disorder of monomeric α-synuclein persists in mammalian cells</article-title><source>Nature</source><volume>530</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1038/nature16531</pub-id><pub-id pub-id-type="pmid">26808899</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trexler</surname> <given-names>AJ</given-names></name><name><surname>Rhoades</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>N-Terminal acetylation is critical for forming α-helical oligomer of α-synuclein</article-title><source>Protein Science</source><volume>21</volume><fpage>601</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1002/pro.2056</pub-id><pub-id pub-id-type="pmid">22407793</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Hole</surname> <given-names>K</given-names></name><name><surname>Pimenta-Marques</surname> <given-names>A</given-names></name><name><surname>Helsens</surname> <given-names>K</given-names></name><name><surname>Vandekerckhove</surname> <given-names>J</given-names></name><name><surname>Martinho</surname> <given-names>RG</given-names></name><name><surname>Gevaert</surname> <given-names>K</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>NatF contributes to an evolutionary shift in protein N-terminal acetylation and is important for normal chromosome segregation</article-title><source>PLOS Genetics</source><volume>7</volume><elocation-id>e1002169</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002169</pub-id><pub-id pub-id-type="pmid">21750686</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Lasa</surname> <given-names>M</given-names></name><name><surname>Polevoda</surname> <given-names>B</given-names></name><name><surname>Gazquez</surname> <given-names>C</given-names></name><name><surname>Elosegui-Artola</surname> <given-names>A</given-names></name><name><surname>Kim</surname> <given-names>DS</given-names></name><name><surname>De Juan-Pardo</surname> <given-names>E</given-names></name><name><surname>Demeyer</surname> <given-names>K</given-names></name><name><surname>Hole</surname> <given-names>K</given-names></name><name><surname>Larrea</surname> <given-names>E</given-names></name><name><surname>Timmerman</surname> <given-names>E</given-names></name><name><surname>Prieto</surname> <given-names>J</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name><name><surname>Sherman</surname> <given-names>F</given-names></name><name><surname>Gevaert</surname> <given-names>K</given-names></name><name><surname>Aldabe</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB</article-title><source>PNAS</source><volume>109</volume><fpage>12449</fpage><lpage>12454</lpage><pub-id pub-id-type="doi">10.1073/pnas.1210303109</pub-id><pub-id pub-id-type="pmid">22814378</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Kalvik</surname> <given-names>TV</given-names></name><name><surname>Starheim</surname> <given-names>KK</given-names></name><name><surname>Jonckheere</surname> <given-names>V</given-names></name><name><surname>Myklebust</surname> <given-names>LM</given-names></name><name><surname>Menschaert</surname> <given-names>G</given-names></name><name><surname>Varhaug</surname> <given-names>JE</given-names></name><name><surname>Gevaert</surname> <given-names>K</given-names></name><name><surname>Arnesen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A role for human N-alpha acetyltransferase 30 (Naa30) in maintaining mitochondrial integrity</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>15</volume><fpage>3361</fpage><lpage>3372</lpage><pub-id pub-id-type="doi">10.1074/mcp.M116.061010</pub-id><pub-id pub-id-type="pmid">27694331</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinueza-Gavilanes</surname> <given-names>R</given-names></name><name><surname>Íñigo-Marco</surname> <given-names>I</given-names></name><name><surname>Larrea</surname> <given-names>L</given-names></name><name><surname>Lasa</surname> <given-names>M</given-names></name><name><surname>Carte</surname> <given-names>B</given-names></name><name><surname>Santamaría</surname> <given-names>E</given-names></name><name><surname>Fernández-Irigoyen</surname> <given-names>J</given-names></name><name><surname>Bugallo</surname> <given-names>R</given-names></name><name><surname>Aragón</surname> <given-names>T</given-names></name><name><surname>Aldabe</surname> <given-names>R</given-names></name><name><surname>Arrasate</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity</article-title><source>Neurobiology of Disease</source><volume>137</volume><elocation-id>104781</elocation-id><pub-id pub-id-type="doi">10.1016/j.nbd.2020.104781</pub-id><pub-id pub-id-type="pmid">31991248</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname> <given-names>MD</given-names></name><name><surname>Lee</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>N-Terminal acetylation affects α-Synuclein fibril polymorphism</article-title><source>Biochemistry</source><volume>58</volume><fpage>3630</fpage><lpage>3633</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.9b00629</pub-id><pub-id pub-id-type="pmid">31424918</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weyer</surname> <given-names>FA</given-names></name><name><surname>Gumiero</surname> <given-names>A</given-names></name><name><surname>Lapouge</surname> <given-names>K</given-names></name><name><surname>Bange</surname> <given-names>G</given-names></name><name><surname>Kopp</surname> <given-names>J</given-names></name><name><surname>Sinning</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Structural basis of HypK regulating N-terminal acetylation by the NatA complex</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15726</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15726</pub-id><pub-id pub-id-type="pmid">28585574</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>D</given-names></name><name><surname>Fang</surname> <given-names>Q</given-names></name><name><surname>Wang</surname> <given-names>M</given-names></name><name><surname>Ren</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>He</surname> <given-names>M</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Yang</surname> <given-names>N</given-names></name><name><surname>Xu</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Nα-acetylated Sir3 stabilizes the conformation of a nucleosome-binding loop in the BAH domain</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>20</volume><fpage>1116</fpage><lpage>1118</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2637</pub-id><pub-id pub-id-type="pmid">23934152</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Gctf: real-time CTF determination and correction</article-title><source>Journal of Structural Biology</source><volume>193</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2015.11.003</pub-id><pub-id pub-id-type="pmid">26592709</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>SQ</given-names></name><name><surname>Palovcak</surname> <given-names>E</given-names></name><name><surname>Armache</surname> <given-names>JP</given-names></name><name><surname>Verba</surname> <given-names>KA</given-names></name><name><surname>Cheng</surname> <given-names>Y</given-names></name><name><surname>Agard</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy</article-title><source>Nature Methods</source><volume>14</volume><fpage>331</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4193</pub-id><pub-id pub-id-type="pmid">28250466</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname> <given-names>L</given-names></name><name><surname>Stephens</surname> <given-names>A</given-names></name><name><surname>Nam</surname> <given-names>SZ</given-names></name><name><surname>Rau</surname> <given-names>D</given-names></name><name><surname>Kübler</surname> <given-names>J</given-names></name><name><surname>Lozajic</surname> <given-names>M</given-names></name><name><surname>Gabler</surname> <given-names>F</given-names></name><name><surname>Söding</surname> <given-names>J</given-names></name><name><surname>Lupas</surname> <given-names>AN</given-names></name><name><surname>Alva</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A completely reimplemented MPI bioinformatics toolkit with a new HHpred server at its core</article-title><source>Journal of Molecular Biology</source><volume>430</volume><fpage>2237</fpage><lpage>2243</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2017.12.007</pub-id><pub-id pub-id-type="pmid">29258817</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zivanov</surname> <given-names>J</given-names></name><name><surname>Nakane</surname> <given-names>T</given-names></name><name><surname>Forsberg</surname> <given-names>BO</given-names></name><name><surname>Kimanius</surname> <given-names>D</given-names></name><name><surname>Hagen</surname> <given-names>WJ</given-names></name><name><surname>Lindahl</surname> <given-names>E</given-names></name><name><surname>Scheres</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>New tools for automated high-resolution cryo-EM structure determination in RELION-3</article-title><source>eLife</source><volume>7</volume><elocation-id>e42166</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.42166</pub-id><pub-id pub-id-type="pmid">30412051</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57491.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Chin</surname><given-names>Jeannie</given-names></name><role>Reviewing Editor</role><aff><institution>Baylor College of Medicine</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Scheres</surname><given-names>Sjors HW</given-names></name><role>Reviewer</role><aff><institution>MRC Laboratory of Molecular Biology</institution><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This work reports a high resolution cryoEM structure of human NatB, whose N-terminal acetylation activity has been linked to both Parkinson's disease and hepatocellular carcinoma. Compared with other NAT complexes, little is known about hNatB. These studies reveal functional features of hNatB, key determinants for α-synuclein N-terminal acetylation, and important residues for substrate-specific recognition and acetylation. These results have implications for the development of drug-like hNatB inhibitors with possible therapeutic applications.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Molecular Basis for N-terminal Α-Synuclein Acetylation by Human NatB&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Huda Zoghbi as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Sjors HW Scheres (Reviewer #1).</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as <italic>eLife</italic> papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity and presentation.</p><p>The two reviewers were positive about your submission, and we will be willing to accept it for publication subject to satisfactory responses to their comments below. N-terminal acetylation of α-synuclein is an area of interest. It is, for example, known to increase the affinity of α-synuclein for lipid membranes; in this context, the recent paper by Runfola et al. should be discussed.</p><p><italic>Reviewer #1:</italic></p><p>This paper describes a cryo-EM structure of human NatB in complex with a CoA-peptide with the N-terminal sequence of human α-synuclein, as well as complementing binding/activity assays with mutants that were designed based on the structure. The cryo-EM structure was done to good standards and the paper is very well written. I am therefore enthusiastic about publication in <italic>eLife</italic> and have only a few relatively minor comments:</p><p>&quot;We therefore incorporated this sequence into a peptide substrate named &quot;MDVF&quot; for an in vitro acetyltransferase assay (see Materials and methods for the full sequence).&quot; I thought this was a 4-residue peptide, but later found out it was longer. Why not just put the entire sequence here in the main text for improved clarity?</p><p>&quot;among where the predicted first and second α-helices were built as poly-alanine due to a lack of resolvable side-chain density (Figure 4—figure supplement 1).&quot; I had hoped to see some of the bad density for these helices in a supplemental figure. Actually, inspection of the map reveals that density is weak up to residue 146. This points to disorder or structural flexibility in this region, which should be explicitly mentioned in the main text. Did the authors try to perform focussed classification with signal subtraction (possibly keeping the orientations fixed) to select a subset of the 1M particles that would be better ordered in this region? Might be worth a try, as it may also provide insights in the nature of the flexibility in this region.</p><p>It would be good to have a figure of the cryo-EM density of the entire complex in a panel in one of the main figures. Currently, there are only a few panels with local zoomed-in views f the reconstructed cryo-EM density.</p><p>FSC curves between the refined PDB model and the cryo-EM are missing. Also, to show that the map was not overfitted, FSC_work and FSC_free curves (where one refines a perturbed model against one half-map and then calculates FSCs of that model against both half-maps) should be included.</p><p>The ResMap doesn't look right: I strongly doubt the local resolution in the N-terminal part of hNAA25 is 4.5A: it looks a lot worse. Perhaps it's just a matter of choosing the colour scale, or perhaps the authors could try RELION's own implementation of local resolution estimation.</p><p>&quot;We demonstrated for the first time that hNatB can acetylate an α-Syn</p><p>peptide in vitro, directly linking hNatB to Parkinson disease.&quot; That is too strong: the structure does not provide a direct link to PD.</p><p>Cryo-EM processing: why was Bayesian polishing not performed? Also, with ~1M particles left, it could be that more classification after the polishing could further improve the map.</p><p>Cryo-EM processing: How was map post-processing (map sharpening) performed?</p><p>Reference Kimanius et al., 2016: better use the RELION-3 reference by Zivanov et al., 2018.</p><p><italic>Reviewer #2:</italic></p><p>Deng et al. present the structure and functional analysis of the human NatB protein, bound to CoA with an αSyn fragment. I only comment on the methodological aspects of the manuscript.</p><p>The method description in the main text is rather short. A Titan Krios with K3 was used, and Table 2 lists parameters. However, these are not sufficient to verify the quality of the work. For example, which software was used for data collection (EPU or SerialEM or other)? How many frames were used per video? What mode of the K3 was used (CDC or Counting)? The magnification is specified as 105kx, but with the 5micrometer pixel size of the K3 that would correspond to a pixel size on the sample of 0.476A at the sample level. However, the Table 2 lists a pixel size of 0.83A per pixel. Is that physical pixel or super-resolution pixel? In any case, the magnification value is probably wrong, and may be a historically originated software bug in the used Titan Krios? Or is that magnification valid for the Flu-screen in the Titan, which has nothing to do with the K3?</p><p>How many KDa is the molecular weight of the determined structure?</p><p>In addition to the model in the PDB, the raw data should be deposited in the EMPIAR and the reconstructed map should be deposited in the EMDB.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Molecular Basis for N-terminal Α-Synuclein Acetylation by Human NatB&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Huda Zoghbi (Senior Editor) and a Reviewing Editor after consultation with the reviewers.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:</p><p>Please confirm that in Figure 2—figure supplement 1, panel D, the model used for the 2 half-map curves was actually refined in one of the two half-maps, and then used for FSC against both half-maps. They should also indicate which of the two half-maps it was refined in. Currently, it reads (which indeed seems to be the case) that these are not the requested FSC_work and FSC_test curves, but that instead they have just used the model from the refinement against the final map to calculate a FSC curve against the two half-maps. That is not informative. The key is refinement in one half-map (which may be overfitted, but this would then show up in a lower FSC curve with the other half-map). This needs to be resolved.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57491.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>The two reviewers were positive about your submission, and we will be willing to accept it for publication subject to satisfactory responses to their comments below. N-terminal acetylation of α-synuclein is an area of interest. It is, for example, known to increase the affinity of α-synuclein for lipid membranes; in this context, the recent paper by Runfola et al. should be discussed.</p></disp-quote><p>In the Introduction, a sentence is added to summarize the results from the recent manuscript by Runfola et al., which demonstrates the importance of N-terminal acetylation on the lipid membrane binding properties of a-synuclein.</p><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>This paper describes a cryo-EM structure of human NatB in complex with a CoA-peptide with the N-terminal sequence of human α-synuclein, as well as complementing binding/activity assays with mutants that were designed based on the structure. The cryo-EM structure was done to good standards and the paper is very well written. I am therefore enthusiastic about publication in eLife and have only a few relatively minor comments:</p><p>&quot;We therefore incorporated this sequence into a peptide substrate named &quot;MDVF&quot; for an in vitro acetyltransferase assay (see Materials and methods for the full sequence).&quot; I thought this was a 4-residue peptide, but later found out it was longer. Why not just put the entire sequence here in the main text for improved clarity?</p></disp-quote><p>Full sequences for the peptide substrates used in the study are now indicated in the main text.</p><disp-quote content-type="editor-comment"><p>&quot;among where the predicted first and second α-helices were built as poly-alanine due to a lack of resolvable side-chain density (Figure 4—figure supplement 1).&quot; I had hoped to see some of the bad density for these helices in a supplemental figure. Actually, inspection of the map reveals that density is weak up to residue 146. This points to disorder or structural flexibility in this region, which should be explicitly mentioned in the main text. Did the authors try to perform focussed classification with signal subtraction (possibly keeping the orientations fixed) to select a subset of the 1M particles that would be better ordered in this region? Might be worth a try, as it may also provide insights in the nature of the flexibility in this region.</p></disp-quote><p>We added a sentence in the main text stating “The N terminal region (residue 1-164) displays relatively weak EM density compared to other regions, suggesting that it is relatively flexible (Figure 2—figure supplement 2).”</p><p>While we agree that further focused classification might improve the local resolution of the N-terminal region, we have chosen not to do this since this region does not appear to mediate biologically important interactions in our structure and would therefore not alter the main conclusions of our study. Nonetheless, the raw cryo-EM data have been deposited in the EMPIAR database so other researchers can access and analyze this dataset further if an interest arises.</p><disp-quote content-type="editor-comment"><p>It would be good to have a figure of the cryo-EM density of the entire complex in a panel in one of the main figures. Currently, there are only a few panels with local zoomed-in views f the reconstructed cryo-EM density.</p></disp-quote><p>We now show the fit of the complex into the cryo-EM density in Figure 2—figure supplement 2, panel D. This figure also illustrates the relatively poor density of the N-terminal region of hNatB.</p><disp-quote content-type="editor-comment"><p>FSC curves between the refined PDB model and the cryo-EM are missing. Also, to show that the map was not overfitted, FSC_work and FSC_free curves (where one refines a perturbed model against one half-map and then calculates FSCs of that model against both half-maps) should be included.</p></disp-quote><p>We have now calculated the FSC curves with the refined PDB model against each half map and the summed map, and show these curves in Figure 2—figure supplement 1 panel D.</p><disp-quote content-type="editor-comment"><p>The ResMap doesn't look right: I strongly doubt the local resolution in the N-terminal part of hNAA25 is 4.5A: it looks a lot worse. Perhaps it's just a matter of choosing the colour scale, or perhaps the authors could try RELION's own implementation of local resolution estimation.</p></disp-quote><p>We thank the review for pointing this out. The previous local resolution map likely did not seem correct because most of the regions of NAA25, except for the N-terminal region (1-164), has a resolution beyond 4.5 Å. We have re-run a ResMap in Relion with different color scale and have illustrated a new local resolution map in Figure 2—figure supplement 1, panel B.</p><disp-quote content-type="editor-comment"><p>&quot;We demonstrated for the first time that hNatB can acetylate an α-Syn</p><p>peptide in vitro, directly linking hNatB to Parkinson disease.&quot; That is too strong: the structure does not provide a direct link to PD.</p></disp-quote><p>We have softened this statement to “directly linking hNatB to NTA of α-Syn”</p><disp-quote content-type="editor-comment"><p>Cryo-EM processing: why was Bayesian polishing not performed? Also, with ~1M particles left, it could be that more classification after the polishing could further improve the map.</p></disp-quote><p>We attempted particle polishing on this dataset, but this surprisingly resulted in artifactual density in the resulting map. We believe that this was due to some small defects in the K3 camera during data collection, which corrupted the particle polishing process. We therefore were unable to exploit particle polishing to improve the resolution of our structure. Instead, two rounds of CTF refinement were performed to achieve the current resolution for model building. This is described in the Materials and methods section of the manuscript.</p><disp-quote content-type="editor-comment"><p>Cryo-EM processing: How was map post-processing (map sharpening) performed?</p></disp-quote><p>This is now explained in the Materials and methods section as follows: After refinement, a mask was created in Relion with an initial binarization threshold of 0.005, covering the protein complex and extending the binary map and soft-edge by 12 pixels. The map was sharpened with the created mask by estimating B-factor automatically in Relion.</p><disp-quote content-type="editor-comment"><p>Reference Kimanius et al., 2016: better use the RELION-3 reference by Zivanov et al., 2018.</p></disp-quote><p>This reference (Zivanov et al., 2018) is now added.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>Deng et al. present the structure and functional analysis of the human NatB protein, bound to CoA with an αSyn fragment. I only comment on the methodological aspects of the manuscript.</p><p>The method description in the main text is rather short. A Titan Krios with K3 was used, and Table 2 lists parameters. However, these are not sufficient to verify the quality of the work. For example, which software was used for data collection (EPU or SerialEM or other)? How many frames were used per video? What mode of the K3 was used (CDC or Counting)? The magnification is specified as 105kx, but with the 5micrometer pixel size of the K3 that would correspond to a pixel size on the sample of 0.476A at the sample level. However, the Table 2 lists a pixel size of 0.83A per pixel. Is that physical pixel or super-resolution pixel? In any case, the magnification value is probably wrong, and may be a historically originated software bug in the used Titan Krios? Or is that magnification valid for the Flu-screen in the Titan, which has nothing to do with the K3?</p></disp-quote><p>We have now added more detail of how the data were collected in the Materials and methods section. With regard to the pixel size, we now indicate that while we used the super resolution mode with a pixel size of 0.415 Å /pixel, we binned the data twofold to 0.83 Å /pixel when motion correction was performed and all further data processing was based on the motion-corrected images with 0.83 Å /pixel.</p><disp-quote content-type="editor-comment"><p>How many KDa is the molecular weight of the determined structure?</p></disp-quote><p>We now indicate in the Introduction section that hNatB is ~130 KDa.</p><disp-quote content-type="editor-comment"><p>In addition to the model in the PDB, the raw data should be deposited in the EMPIAR and the reconstructed map should be deposited in the EMDB.</p></disp-quote><p>We have now deposited the raw data (Raw videos, picked-particle star file and others) into EMPIAR with access ID of EMPIAR-10477. This information is now added in Table 2. The model and map will be released when the manuscript is published, with access ID of PDB 6VP9, or EMD-21307.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>Please confirm that in Figure 2—figure supplement 1, panel D, the model used for the 2 half-map curves was actually refined in one of the two half-maps, and then used for FSC against both half-maps. They should also indicate which of the two half-maps it was refined in. Currently, it reads (which indeed seems to be the case) that these are not the requested FSC_work and FSC_test curves, but that instead they have just used the model from the refinement against the final map to calculate a FSC curve against the two half-maps. That is not informative. The key is refinement in one half-map (which may be overfitted, but this would then show up in a lower FSC curve with the other half-map). This needs to be resolved.</p></disp-quote><p>We thank the reviewer for pointing out this mistake. We have now refined the model in one of the independent half maps (in the new figure, we actually refined the model in half map 2), and then used the newly refined model to calculate the FSC curves against both independent half maps. The figure is now replaced with a new one, and the figure legend is updated to indicate which half map was used to refine in, to distinguish FSC_work and FSC_test.</p></body></sub-article></article>